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Why sexual abuse? 
 
 “Why sexual abuse as topic of your dissertation?”,  is a question asked frequently. As an answer I 
often tell the anecdote of my urology training in Leiden.  
While performing a rectal examination, a patient started screaming and shouted that I was raping 
him. When he calmed down, he told me that he was sexually abused as a teenager and during the 
examination he relived the abuse. I got interested in the subject of sexual abuse and wondered 
what the prevalence was of sexual abuse. Are patients with sexual abuse avoiding the urologist? Is 
the prevalence of sexual abuse in the urologic clinic lower than in general population?  
Do the sexual abused patients develop certain symptoms? Do urologists see patients with a history 
of sexual abuse more often than other medical experts, like a dermatologist for example?  
Furthermore, do urologists ask their patients about sexual abuse history? Because, I didn’t! 
Otherwise I would have taken precautions, before performing a rectal examination to the patient in 
the anecdote. I also wondered if some signs of sexual abuse are available, so an urologists can 
predict the chance of sexual abuse history and ask for it. Hardly any literature on this topic was 
found in literature related to urology. This in contrast to paediatricians and gynaecologists who did a 
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Chapter 1:   
 











































































Prevalence of sexual abuse 
Sexual abuse (SA) is defined by International Society for the Prevention of Child Abuse and Neglect 
as ”a social and medical problem in which a child under the age of consent is involved in an act 
resulting in sexual satisfaction of an adult or connivance of such an act”1.  The frequency in which 
children are exposed to sexual advances from adults varies according to the definition of abuse, the 
age range studied, and the methods of ascertainment. The prevalence of SA is estimated to be 12% 
to 25% for females and 8% to 10% for males2. SA can also occur after childhood, for example as 
rape or sexual violence. Some assumptions can be made regarding SA-prevalence in urological 
practice. The prevalence of SA at an outpatient urology clinic is the same as in general population. 
Or, prevalence is lower than in general population, because patients with SA tent to avoid the 
urologist. Or, prevalence is higher, because SA can give certain urological complaints, for which they 
tend to see the urologist more often.  
 
Inquiring sexual abuse  
Clinicians have limited time with each patient and are responsible for screening for many different 
disorders and conditions. In practice, inquiry about SA is not part of routine care, even when 
clinicians believe it may be relevant3,4. Despite a possible relation of urologic symptoms and a 
history of SA, little to nothing is known about SA history taking in routine urological practice. This is 
in sharp contrast to paediatric, gynaecological, general physician, gastro-enterological and 
psychiatric practice2-10. Over 20 years ago, gynaecologists argued that a brief sexual inquiry was 
much more helpful than waiting for the patient’s own story about SA11. Fear for unpredictable 
patient reactions may be an important reason why physicians hardly ask about SA history12. 
However asked in a compassionate and accurate way, it seldom will lead to unpleasant reactions13. 
Asked in a questionnaire before their first visit to a urologist, most female patients mention their SA 
history14. Does this imply that sexual abuse survivors think it is important information for their 
urologist?  
 
Inquiring sexual functioning 
As in inquiring SA, inquiring female sexual dysfunctions (FSDs) can help the physician in treating the 
patient better. And as in inquiring SA, the urologists’ attitude towards inquiring FSDs is unclear. A 
number of studies have demonstrated a strong association between pelvic floor disorders, lower 
urinary tract symptoms, overactive bladder with or without urinary incontinence, and FSD15-22.  Does 
this imply that urologist screen their patients for FSD? 
 
Sexual abuse and physical complaints 
It is postulated that SA might lead to a variety of symptoms in one domain of the pelvic floor23. 
Several studies mentioned the urological domain of the pelvic floor24-28. A lot of studies mentioned 
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the gastro-intestinal domain29-35. Also the gynaecological domain of the pelvic floor is related to SA 
history36-41. It has been hypothesized that patients with pelvic floor dysfunction have voiding 
difficulties due to a higher tone at rest of the pelvic floor42. Many of them have episodes of 
obstructive voiding complaints42. As in benign prostate hyperplasia, long-lasting bladder outlet 
obstruction can lead to storage symptoms like urinary frequency, urgency, urgency incontinence, 
and nocturia43-45.  Can we relate certain pelvic floor complaints to SA? Can we relate certain 
urological complaints to SA? 
 
Pelvic floor and sexuality research group 
The Department of Urology of the Leiden University Medical Center has a long tradition of male 
sexual function research. In 1978 professor U. Jonas started implanting the semi-rigid erection 
prosthesis. Professor P. Donker and P. Walsh wrote the article on nerve-sparing radical 
prostatectomy, as a result of a visit of Walsh to Donker in Leiden in 198146. Giesbers, Kropman, 
Meinhardt and Lycklama à Nijeholt published several studies about the diagnosis and treatment of 
erectile dysfunction. In 2004 the Department of Urology founded the Pelvic Floor & Sexuality 
Research Group Leiden. The mission of the research group is initiating pelvic floor and sexuality 
related research. Since the kick-off in 2004 three dissertations were completed. In 2008 Dr. Petra 
Voorham- Van der Zalm completed the thesis “Towards evidence based practice in pelvic floor 
physiotherapy” and Dr. Henk Elzevier completed the thesis “Female sexual function in urological 
practice”. In 2010 Dr. Milou Bekker completed the thesis “Female sexual function and urinary 
incontinence”. This thesis will be the fourth thesis of the Pelvic Floor & Sexuality Research Group 
Leiden.    
 
Aims of the thesis 
The primary aim of this study is to investigate the prevalence of SA in a urological outpatient clinic. 
Can differences be made in urological population, i.e. general urological clinic, a university urological 
clinic and a tertiary university pelvic floor clinic? Do urologists inquire about FSD and SA history? 
And if so, what percentage of the Dutch urologist does so? What do SA  patients think about 
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PART II  
 
PREVALENCE AND EVALUATION OF SEXUAL ABUSE 



















































Chapter 2:   
 
The place of female sexual dysfunction in the urological 
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Introduction: Female sexual dysfunction (FSD) is a highly prevalent and often underestimated 
problem. There is a strong association between urological complaints and FSD. 
Aim: The purpose of this survey was to evaluate how Dutch urologists address FSD in their 
daily practice. 
Methods: We performed an anonymous survey study. A 17-item anonymous questionnaire was 
mailed to all 405 registered members of the Dutch Urology Association (urologists and residents 
in urology).  
Main Outcome Measures: The survey results. 
Results: One hundred eighty-six complete surveys of eligible respondents were returned 
(45.9% response rate). Ten respondents (5.5%) stated that they ask each female patient for 
sexual function; 81.8% stated that they ask for sexual function when a patient has certain 
complaints. In specific complains about lower abdominal pain (86.8%), incontinence (73.6%), 
urgency or frequency (77.1%), or urinary tract infections (66.7%) are reasons for inquiring FSD. 
Many respondents (40.3%) do not think that FSD is meaningful in a urological practice.  The 
majority of respondents (91%) underestimate the frequency of FSD in a urological clinic. 
Respondents who believe the frequency of FSD to be at least 30% tend to ask more often for 
sexual function than the rest of the group (p=0.08).  
Conclusion: Overall, many urologists do not consistently ask each female patient for sexual 
function and underestimate the prevalence of FSD. For the majority of the members of the 
Dutch Urological Association, FSD is not part of routine urological practice. There is, therefore, a 
















Female sexual dysfunctions (FSDs) are highly prevalent and often underestimated problems in the 
general community1. However, FSDs have not yet been studied as extensively as male sexual 
dysfunction. Improved knowledge on the female pelvic anatomy and recent insights in female sexual 
physiology helped to classify FSDs more adequately. Today, FSD is a term used to describe various 
sexual problems, such as low desire or interest, orgasmic difficulties, diminished arousal, and 
dyspareunia2,3. Due to the use of different instruments, published prevalence estimates of FSD show 
a great deal of variation4. FSD is considered common in the general population, with a quoted 
prevalence of 43%1,5,6. In these studies, however, distress caused by sexual dysfunction has not 
been inquired. The prevalence of sexual problems accompanied by personal distress was estimated 
to be 12–24% from large population based surveys in the United States1,3,5. A number of studies 
have demonstrated a strong association between pelvic floor disorders, lower urinary tract 
symptoms, overactive bladder with or without urinary incontinence, and FSD7-14. The prevalence of 
FSD in sexual active women attending a urogynecologic outpatient clinic ranges from 48% to 64%, 
which is higher than the afore mentioned 43% in the general population15,16. In patients attending a 
urogynecologic outpatient clinic, FSD is unlikely to be the sole complaint, i.e., the reason for women 
to consult their urogynecologist. Only seven out of 70 women with FSD presented with this problem 
at a urogynecology clinic16. Therefore, women who seek urological care will be of greater risk of 
having sexual function disorders and urologists should be aware of this potential coexisting problem. 
Besides the frequent coexistence of FSD in patients with urological complaints, urological surgery 
such as (simple/radical) cystectomy, prolapse, and incontinence surgery may enhance FSD17,18. 
Sexual dysfunction may arise due to nerve or vessel damage and/or alteration of vaginal anatomy. 
In this respect, the growing interest in the preservation of the neurovascular bundles is an 
important new topic in oncological pelvic surgery19. Literature on incontinence surgery is conflicting: 
some reports suggest a deterioration of sexual function20-22. Some report an equivocal effect23-27. 
Whereas others show improvement28-34. Whatever the effect may be, the possible effects on 
sexuality should be discussed both pre and postoperatively with the patient and her partner. A web-
based survey of 3,807 women aged 18–75 years in the United States indicated that the most 
important barriers for women to seek help were embarrassment and the idea that physicians would 
not be able to provide adequate help35. Only 42% of this cohort sought help from a physician. In 
our experience, there appears to be two major groups of women suffering from FSD, namely those 
who present symptoms and those who prefer not to broach the subject and perhaps hope that the 
discussion will emerge during the consultation. Therefore, the doctor is the pivot on which 
discussing FSD hinges, and he or she should therefore be proactive and endeavour to identify sexual 
problems. Recent surveys among members of the American Urogynecologic Society (AUGS) and the 
British Society of Urogynecology (BSUG) showed that only a minority screened all their patients for 





The purpose of this survey was to investigate whether Dutch urologists and residents address 
patients’ sexual function as part of history taking, to delineate perceived barriers to perform this 
assessment, and to document current attitudes toward FSD.  
 
Methods 
In the autumn of 2007, a questionnaire was mailed to all urologists and residents registered at the 
Dutch Urologic Association (405). Nearly all Dutch urologists and residents are members of this 
association (20% female, 80% male). The 17-item questionnaire (Appendix) was designed by a 
urologist/sexologist from our clinic in order to address FSD-related practices at outpatient clinic 
visits, beliefs, and overall impression of FSD and FSD related to surgery. Five of the 17 questions 
concerned the topic of taking the history of possible sexual abuse. Sexual abuse is strongly related 
to urological complaints and sexual dysfunction. Because of its complexity, it was decided to present 
these data separately. Demographic data included type of practice, medical degree (resident or 
urologist), gender, and age. The survey was accompanied with a letter explaining the objectives of 
the study. All date were collected anonymously. We analyzed the data using SPSS release 16 (SPSS 
Inc., Chicago, IL, USA). Bivariate associations between demographic information and frequency of 
FSD screening were calculated using the chi-square procedure and P values <0.05 were considered 
statistically significant. Ethical approval was not required and thus not asked for in this study. 
 
Results 
Of the 405 mailed surveys, 190 were completed and returned. From the 215 nonrespondents, we 
did not receive a refusal note or notification of unavailability to complete the questionnaire. Four 
questionnaires were from non-eligible respondents, namely paediatric urologists. Their 
questionnaires were excluded for analysis. All returned surveys were complete, i.e., more than 80% 
of all applicable questions were answered. For analysis, we used the completed questionnaires of 
eligible respondents which gave a response rate of 45.9% (186/405). One hundred respondents 
requested the survey results to be mailed at the end of the study (53.8%). The majority of 
respondents were urologists (79.6%) and most (65.5%) were between 31–50 years old. Consistent 
with the distribution within the surveyed population, there were more male respondents (82.8%) 
than female (17.2%). Forty-seven percent of the respondents worked in a district general hospital, 
29% in a district general teaching hospital, and 24% in an academic teaching hospital. The 
demographic characteristics are presented in Table 1. Demographic information was not tracked by 
the Dutch Urologic Association and, therefore, characteristics of nonrespondents were not available 
for comparison. One of the primary goals of the survey was to assess if urologists and residents 
address patients’ sexual function as part of history taking. Only 10 respondents (5.4%) stated that 
they ask each female patient for her sexual function. In contrast, 81.8% stated that they ask for 
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sexual function when a patient has a specific complaint like lower abdominal pain (86.8%), urgency 
or frequency (77.1%), incontinence (73.6%), and urinary tract infections (66.7%). Among “other 
complaints” to ask for female sexual function, the respondents mentioned dyspareunia, pelvic floor 
dysfunction, and neuropathic bladder disorders. See Table 2.  
 














n               (%) 
Age (years) 
20-30 
3 1.6 % 






8 4.3 % 
missing 
2 1.1 % 
Gender 
Male 154 82.8% 
Female 32 17.2% 
Medical degree 
Urologist 148 79.6% 
Urology resident 38 20.4% 
Type of clinic/practice 
Academic (teaching) hospital 44 23.7% 
District general teaching hospital 54 29.0% 









We were also interested in reasons why 176 respondents do not ask each patient for sexual 
function; 40.3% stated that they do not find it meaningful in urological practice, 22.7% mentioned 
insufficient knowledge about how to ask for FSD, others stated lack of time (18.2%), and others 
stated lack of knowledge in therapeutic options if they diagnose FSD (13.6%). Only a minority 
(10.8%) said that they find it difficult to bring up the subject. Other reasons given (12.5%) were 
“older patients (especially those without a partner),” “no relevance to ask for FSD, for example, 
when a patient suffers from urinary stone disease,” and “FSD belongs to the field of a gynecologist.” 
There was a significant difference in age of respondents who stated to have insufficient knowledge 
about how to ask for FSD, i.e., respondents aged 40 years and younger (16/65) more often feel 
their insufficient knowledge in asking for FSD as a reason not to ask for sexual function than older 
colleagues (24/109) (p=0.01). Another goal of our survey was to document physicians’ perception 
of the prevalence of FSD. Respondents were asked to esteem how many of their patients are 
experiencing sexual dysfunction. The majority reported less than the estimated 48–64% of 
patients15,16. Of the respondents, 37.8% believed that less than 10% of their patients suffer from 
  
  
n                     % 
Do you ask each patient for sexual function? 
  
n=186 
Yes 10 5.4% 
No 176 94.6% 
Do you ask for sexual function when a patient has 
certain urological complaints? 
n=176 
Yes 144 81.8% 




Lower abdominal pain 125 86.8% 
Urgency or frequency 111 77.1% 
Incontinence 106 73.6% 
Urinary tract infections 96 66.7% 
Hematuria 4 2.8% 
Other 9 6.3% 
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FSD. Prevalences of 11–20%, 21–30%, 31–40%, 41–50%, and 51–60% were estimated by 
22.8%, 20.6%, 10%, and 6.7%, respectively. Only 2.2% estimated between 51% and 60%. No 
respondents perceived a prevalence of FSD higher than 60%. Nine respondents acceded to have 
no insight in the frequency of FSD in their patient population whatsoever and, therefore, did not 
give a percentage (missing) (Figure 1). In the group of responders, who thought of a prevalence 
of at least 30% or higher (n=58), 10.3% asked each patient for sexual function and 84.5% 
asked for sexual function when a patient had a specific urological problem. Compared with the 
rest of the group, respondents who believed the frequency of FSD to be at least 30% tended to 
ask for FSD more often, but no statistical significant difference was found (p=0.08). These 
groups showed no significant difference in asking for sexual function when a 
 patient has a specific urological complaint (p=0.57).  
 
Table 3: Frequency of asking for sexual function when a patient has a specific 






Ask for sexual function when a patient 
has a urological complaint 




126 22 148 
1.00 
Resident 
28 10 38 
Type of practice 
Academic (teaching) 
hospital 
36 8 44 
0.98 
District general teaching 
hospital 
45 9 54 
District general hospital 
73 15 88 
Gender 
Male 
127 27 154 
1.00 
Female 
27 5 32 
Age 
< 40 years 
56 13 69 
0.69 
> 40 years 
97 18 115 
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One hundred seventy (91.4%) respondents stated that female sexual function should be prior to a 
radical cystectomy, the potential effects of surgery on sexual function were discussed with patients 
by 83.9% of the respondents, by 81.2% prior to a simple cystectomy, and by 58.6% prior to 
incontinence surgery. After surgery, patients are asked for changes in sexual function by 47.3%. 
integrated in postgraduate urological training programs. Analysis performed to determine whether 
certain demographic factors had any impact on frequency of asking for sexual function when a 
patient has a specific urological complaint showed no statistical differences in frequency of screening 
bases on medical degree, type of practice, gender, or age.  
 
Figure 1: Physician perceptions of the prevalence of FSD in their patient population 
 
Discussion 
This study was performed to asses the approach of Dutch urologists toward FSD in urological 
patients. Most urologists do not consistently address FSD. The prevalence of FSD is underestimated 
and not all urologists address FSD prior and following surgery. This survey had a response rate of 
45.9% which is equal to the previous survey among AUGS members but lower than the 67% 
response in the British survey36,37. Our response rate is higher than the average, observed in postal 
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questionnaires38. This may be due to a second preannounced mailing, after which, the response rate 
nearly doubled. This study has some limitations. First, the use of a nonvalidated questionnaire with 
dichotomic answers and without cultural components were taken into account. Second, as 
nonrespondents may have different beliefs, attitudes, and practice patterns than responders, there 
may be a selection bias. As in  all questionnaire studies, there may be a bias in reporting, as the 
respondents may overestimate frequency of asking for sexual function in their practices. However, 
attempts were made to reduce such a bias by making the survey anonymous. Recent surveys 
among members of the AUGS and among members of the BSUG showed that only a minority screen 
all patients for FSD (22% and 0%, respectively). Lack of time, uncertainty about therapeutic 
options, and older age of the patient were cited as potential reasons for failing to address sexual 
complaints as part of routine history36,37. Although we did not use the same questionnaire, some 
comparisons to the American and British surveys can be made. Similar in all three surveys is that 
only a minority of respondents ask each patients for female sexual (dys)function. When asked for 
reasons not to address FSD, the majority of the American and British respondents stated lack of 
time to screen for FSD after surgery (78% and 66%), while in our survey, only 18.2% stated lack of 
time. Another objection given in these surveys was fear of, by asking for FSD, offending their 
patients. In our survey, we did not ask for this objection; however, respondents did not state this 
barrier at the “Other” answers. When asked for reasons not to ask, female sexual function is 
thought not to be meaningful in a urological practice, while it is known that there is a strong 
association between FSD and urological problems. Obviously, this is contradictory. Unfortunately, 
the survey did not give us information about why urologists think female sexual function to have no 
meaning in their practices. One would expect an increased attention to sexual disorders in urologists 
with special interest in treatment of lower urinary tract disorders, but unfortunately, we have no 
data on this issue. Although respondents stated they think female sexual function not to be 
meaningful, they agreed that female sexual function should be part of their graduate and 
postgraduate training. Even though female sexual function is  included as a required topic in the 
education of urology residents and currently part of graduate and postgraduate training programs, a 
reason not to ask for sexual function was insufficient knowledge about how to ask for FSD, 
especially for respondents aged 40 years and younger. This illustrates the fact that, apparently, 
current training programs are insufficient. Furthermore, even though older urologists have dealt with 
sexual dysfunction in men for decades, the interest in female sexual function lags behind. Only 
during the last 5 years, female sexuality has become a topic in the training of urology residents. 
Important in this respect is the underestimation of the frequency of FSD in a urological practice. The 
majority reported a prevalence far below the estimated prevalence of 48–64% of patients15,16. 
Reasons for this underestimation could be insufficient education or lack of interest in FSD. The 
group of 58 respondents who estimated a frequency of FSD of at least 30% does not ask more 
often for FSD. So, even if a doctor has knowledge of the prevalence of FSD, asking for sexual 
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function is still not part of the daily routine. Lack of knowledge and also understanding may 
contribute to many doctors’ lack of willingness to deal with the sexual issues. It is known that 
urological surgery such as a cystectomy, prolapse, and incontinence surgery may enhance FSD17,18.  
Prior to a (simple or radical) cystectomy, the possible effects on sexual function are discussed with 
patients by most of the urologists (81.2% and 83.9%). Before incontinence surgery, however, only 
58.6% discuss potential risks. Perhaps, not all urologists are aware that not only surgery such as a 
cystectomy but also surgery for incontinence may cause FSD. Remarkably, even though most 
urologists discuss it prior to surgery, only 47.3% ask if  changes in sexual function have occurred 
after surgery. Unfortunately, the questionnaire does not provide us the information why urologists 
do not ask for changes in sexual function after surgery, but this topic does need attention. After 
surgery, patients should be assessed for sexual problems and informed on therapeutic options. In 
both the FSD, as the surgery related FSD section of the questionnaire, no gender-related differences 
were found. The results of this survey show that awareness of FSD is apparently insufficient. There 
is a need for better implementation of education and training at both undergraduate and 
postgraduate levels. Education should inform clinicians about the prevalence and the current 
knowledge of FSD, especially in relation to urological complaints and treatments. Furthermore, 
training should be based on studies on women’s attitudes toward sexuality in relation to the 
expectations of the physician. Women expect initiatives from physicians in raising the issue of sexual 
health. They want both routine and more frequent physician inquiry about sexual concerns, as well 
as a more open, clear, comfortable, and empathic discussion of these issues39. Physicians should be 
aware of their patients’ needs in this area. Because lack of time is also mentioned as a reason not to 
ask for sexual function, urologists should be trained in time management strategy. Furthermore, 
training should aim to teach urologists how to communicate more effectively with patients as this is 
important in assessment of FSD40. Finally, they should be informed about the validated 
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Female sexual function 
 
1. Do you ask each female patient for sexual function?     Yes   No  
2. Do you ask for sexual function in female patients with specific urological  
 complaints?        Yes   No  
3. If so, which urological complaints? 
Hematuria         Yes  No   
Incontinence        Yes  No   
Urgency and frequency       Yes  No   
Lower abdominal pain       Yes  No   
Urinary tract infection       Yes  No   
    Other,          ____ 
4.  A reason not to ask is;  
I don’t find it meaningful in a urological clinic    Yes  No   
Not enough time       Yes  No   
I find it difficult to address      Yes  No   
I have insufficient knowledge how to ask for FSD   Yes  No   
If a patient has FSD, I am unsure about therapeutic options  Yes  No   
Other,               ____  
5  What percentage of female patients that you see do you believe experience sexual 
 dysfunction? (Please give a percentage) 




6. Do you always ask patients before performing a physical examination for a history of 
negative sexual experiences (sexual abuse)?       
         Yes  No  
7. Do you ask patients with specific urological complaints for a  
 history of negative sexual experiences (sexual abuse)?   Yes  No  
 
8.      If so, which urological complaints? 
Hematuria        Yes  No  
 Incontinence       Yes  No  
 Urgenc and frequency      Yes  No  
 Lower abdominal pain      Yes  No  
 Urinary tract infection      Yes  No 
    Other,         
 9.  A reason not to ask is; 
  I don’t find it meaningful in a urological clinic   Yes  No  
  Not enough time      Yes  No  
  I find it difficult to address     Yes  No  
  I do not know what/how to ask     Yes  No  
 If a patient has a problem I am unsure about  
 therapeutic options      Yes  No  
    Other,        
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10. What percentage of female patients that you see do you believe have a history of sexual 
 abuse? (Please give a percentage)   %  
 
Surgery and female sexual dysfunction  
 
11. Do you address the (possible) effects of surgery on female sexual function prior to the following 
procedures? 
  Radical cystectomy  Yes   No   
  Simple cystectomy  Yes   No   
  Incontinence surgery  Yes   No   
 
12. Do you ask for the (possible) effects of these surgeries on female sexual function after the 
procedure?    Yes   No   
 
13. Should female sexual function related to urology be integrated in post-graduate training 




14. What is your age?        Years 
 
 
15. What is your gender?     Male  
      Female  
 
16. What is you profession?     Urologist 
      Resident urology  
      Paediatric urologist  
 
17. Where do you work?  
      Academic  
      (teaching) hospital     
      District general teaching hospital  
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Introduction: There is a strong association between urological complaints and a history of sexual 
abuse, especially in females. It is not known whether urologists integrate these facts in their daily 
practice. 
Aim: To evaluate whether Dutch urologists address the issues of sexual abuse in their female 
patients and to evaluate their perception of sexual abuse prevalences. 
Methods: A five-item anonymous questionnaire was mailed to all 405 registered members of the 
Dutch Urology Association (urologists and residents). 
Main outcome measures: The results of the survey. 
Results: One hundred eighty-six surveys of eligible respondents were returned (45.9% response 
rate). A total of 68.8% stated that they always ask their female patients about sexual abuse before 
doing the physical examination. Overall, 79.3% said to do so when a patient has certain urological 
complaints: 77.6% in case of lower abdominal pain, 62.1% in urgency or frequency, 41.4% in 
incontinence, 29.3% in urinary tract infections, and 3.4% in hematuria. The majority of the 
respondents (74.3%) estimated the frequency of sexual abuse in their urological clinic to be equal 
or less than 10%. 
Conclusions: Nearly 70% of the responding Dutch urologists and residents ask their female 
patients about possible sexual abuse. They estimate the frequency of sexual abuse in their female 





















International estimates of the prevalence of sexual abuse are high. Recently, the Committee on 
Child Abuse and Neglect suggested that each year, approximately 1% of children experience some 
form of sexual abuse, resulting in the victimization of 12% to 25% of females and 8% to 10% of 
males1. After the first scientific report by Reinhart et al. in 1989 about sexually abused children and 
urinary tract symptoms, several authors have found an association between urological symptoms 
and a history of sexual abuse in adult patients2-11. Clinicians have limited time with each patient and 
are responsible for screening for many different disorders and conditions. In practice, inquiry about 
sexual abuse is not part of routine care, even when clinicians believe that it may be relevant12,13. 
Despite the strong association of urologic symptoms and a history of sexual abuse, little to nothing 
is known about sexual abuse history taking in routine urological practice. This is in sharp contrast to 
paediatric, gynaecological, general physician, gastroenterological and psychiatric practice1;12-19. 
 
Aims 
The purpose of our research was to evaluate the sexual abuse assessment by urologists and their 
estimation of sexual abuse prevalence in their female patients. 
 
Methods 
In the autumn of 2007, a questionnaire was mailed to all urologists and residents registered at the 
Dutch Urologic Association (n=405). All of them are member of this association (80% male, 20% 
female). The 17-item questionnaire, designed by the sexologist from our clinic, addresses female-
sexual-dysfunction-related practices at outpatient clinic visits, beliefs and overall impression of 
female sexual dysfunction and female sexual dysfunction related to surgery20. Five of the 17 items 
concern the topic of taking the history of possible sexual abuse (See Appendix: translated from 
Dutch). Demographic data included type of practice, medical degree (resident or urologist), gender, 
and age. The survey was accompanied with a letter explaining the objectives of the study. We 
analyzed the data using SPSS release 16 (SPSS Inc., Chicago, IL, USA). Bivariate associations 
between demographic information and frequency of sexual abuse screening were calculated using 
the chi-square procedure; p<0.05 was considered statistically significant. Ethical approval was not 
required and was thus not asked for in this study. 
 
Results 
Of the 405 mailed surveys, 190 were returned. None of the returned surveys had a missing page 
and approximately 80% of all questions were answered. Daily adult urological care was the context 
of our study, so the questionnaires from paediatric urologists (n=4) were excluded for analysis. This 
gave a response rate of 45.9% (186/405). The majority of respondents were urologists (79.6%), 
and most of them (65.5%) were between 31 and 50 years old. In correspondence with the m/f ratio 
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in Dutch urology, there were more male respondents (82.8%) than female (17.2%). Forty-seven 
percent of the respondents worked in a district hospital, 29% in a general teaching hospital, and 
24% in a university hospital. A total of 68.8% stated that they always ask their female patients for 
sexual abuse before doing the physical examination. Overall, 79.3% said to do so when a patient 
has certain urological complaints: 77.6% in case of lower abdominal pain, 62.1% in urgency or 
frequency, 41.4% in incontinence, 29.3% in urinary tract infections, 3.4% in hematuria, 3.4% in 
neurogenic bladder, 1.7% in dyspareunia, and 1.7% in pelvic floor dysfunction. The arguments for 
not asking about possible sexual abuse are summarized in Table 1; "Not important in urological 
practice" was mentioned most frequently. Demographic factors had no impact on the frequency of 
asking about possible sexual abuse (medical degree p=0.56, type of practice p=0.46, gender 
p=0.21, and age p=0.62). The majority (74.3%) of the respondents estimated the frequency of 
sexual abuse in their urological clinic to be equal or less than 10%. Prevalence rates of 11–20%, 
21–30%, 31–40%, and 41–50% were estimated by 7.5%, 3.7%, 1.6%, and 0.5%, respectively. No 
respondents perceived a prevalence rate higher than 50%. Twenty-three respondents (12.3%) had 
no insight at all and, therefore, did not give a percentage. Respondents who estimated the sexual 
abuse prevalence to be higher than 10% did not ask for sexual abuse history more frequently than 
those who thought it to be equal to or less than 10% (p<0.005). 
 











“I don’t think it’s important in urological practice.” 20 34.5% 
“I don’t know what to do if a patient has 
experienced sexual abuse.” 
9 15.5% 
“I find it difficult to bring up.” 9 15.5% 
“I don’t have enough time” 6 10.3% 
“Other” : sexual abuse history is not relevant 
for the treatment of kidney stones or colic pain 
2 3.4% 
Question not answered 12 20.8% 
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Year of  
Publica- 
tion 
Friedman et al. 12 Physicians 11% 1992 
Walker et al.21 General practitioners 4% 1993 
Pearse et al.22 General practitioners 21% 1994 
Read et al. 19 Psychiatrists 32.1% 1998 
Pearse et al.22 General practitioners 21% 1994 
Maheux et al.16 General practitioners 2,3% 1999 
Maheux et al.16 Obstetricians-gynecologists 1.3% 1999 
Ilnyckyj et al.13 
Gastroentorologists inquiring female 
IBS patients 
50% 2002 
Perscher et al.23 Gynecologists 0.5 % 2005 




This study was performed to evaluate the sexual abuse assessment by Dutch urologists and their 
perception of sexual abuse prevalence in their female patients. To our knowledge, this is the first 
report on this topic ever. Most respondents (68.8%) consistently inquire about sexual abuse in their 
patients' history. This is higher compared to other health care providers12,13,16,19;21-23. Their 
percentages are listed in Table 2. A possible explanation of the high percentage of Dutch urologists 
inquiring about sexual abuse is that the responding urologists overestimate their inquiring. A second 
explanation can be selection bias, because it is possible that only urologists with an affinity for 
inquiring abuse answered the questionnaire. It is also possible that urologists, in contrast to other 
health care providers, are not afraid of intimate questions like sexual abuse, because they also 
inquire their patients for erectile dysfunction or (coital) incontinence. Nevertheless, with these 
nuances in mind, it is still a surprisingly high percentage. This study has some limitations. The first 
limitation is our use of a non-validated questionnaire. As in most questionnaire studies, there may 
be a bias in reporting. The respondents may have overestimated the frequency of asking for sexual 
abuse. However, attempts were made to reduce such bias by making the survey anonymous. The 
response rate was 45.9%, which is higher than the average in postal questionnaires24. This may be 
due to a second pre-announced mailing, after which the response rate nearly doubled. Over 20 
years ago, gynaecologists argued that a brief sexual inquiry was much more helpful than waiting for 
the patient's own story about sexual abuse25. A large cross-sectional, multicenter study of 3,641 
females attending five gynaecological departments in Denmark, Finland, Iceland, Norway, and 
Sweden revealed that 92% had not talked to their gynaecologist about their history of sexual 
abuse26. Fear for unpredictable patient reactions may be an important reason why physicians hardly 
ask about sexual abuse history23. However, when asked in a passionate and accurate way, it seldom 
will lead to unpleasant reactions27. Asked in a questionnaire before their first visit to an urologist, 
most female patients mention their negative experiences28. This implies that sexual abuse survivors 
think it is important information for their urologist. It is important for urologist to address this issue 
with patients because a urological physical examination almost often implies an inspection and 
palpation of the genitals. This is in contrast to a primary care physician, who also examines less 
private body parts such as an ear or a shoulder. The importance of discussing abuse before 
performing a gynaeco-urological examination is clear. Survivors of sexual abuse rate their 
experiences with gynaecological care more negatively than controls, they have more negative 
feelings, and report more discomfort at almost every stage of the gynaecological examination. They 
also report more trauma-like responses during the gynaecological examination, including 
overwhelming emotions, intrusive or unwanted thoughts, memories, and feelings of body 
detachment17,18;29,30. Physicians should realize that any kind of uro-gynaecological examination may 
trigger a flash-back of abuse and retraumatize these females31. In published literature, frequency, 
urge, incontinence and dysfunctional voiding are mentioned most frequently as urological symptoms 
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correlated to sexual abuse history3,5,6,8,10,11. A pelvic floor dysfunction can be the link between sexual 
abuse history and urological symptoms. Sexual abuse history is more often found in patients with 
multiple pelvic floor complaints4. Pelvic floor dysfunction is correlated to urological complaints like 
frequency, urge incontinence, and dysfunctional voiding. Therefore, sexual abuse can give pelvic 
floor dysfunction, which can cause urological complaints. Most respondents in our survey think the 
prevalence rate of females with a history of sexual abuse to be equal or less than 10%. In the 
Netherlands, the prevalence rates of sexual abuse vary from 10.9% to 23.5% (Table 3). Further 
investigations of the impact of sexual abuse at daily urological care are mandatory. 
 
Conclusion 
Nearly 70% of the Dutch urologists ask their female patients about their sexual abuse history. They 
estimate the frequency of sexual abuse in a urological clinic to be equal to or less than 10%. 
 
























Draijer et al.32 Females 20-40 years 248 1054 23.5% 1990 
Lankveld et al.33 
Non-oncologic gynecology 
patients 
50 325 15.4% 1996 
Van der Hulst et al.34 
Low-risk pregnant women 
(non-clinical) 
70 625 11.2% 2006 
Lamers-Winkelman35 11-18 years old students 108 * 989 * 10.9%  2007 
Beck et al. 4 
Female patients at a 
academic pelvic floor 
center 
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Do you always ask patients before performing a physical examination for a history of 
negative sexual experiences (sexual abuse)?      Yes   No   
 
Do you ask patients with specific urological complaints for a history of negative sexual 
experiences (sexual abuse)?        Yes   No   
 
If so, which urological complaints?  
Hematuria        Yes   No   
Incontinence       Yes   No   
Urgency and frequency      Yes   No   
Lower abdominal pain      Yes   No   
Urinary tract infection      Yes   No   
Other,   _____________________  
    
A reason not to ask is; 
 I don’t find it meaningful in a urological clinic  Yes   No   
 Not enough time      Yes   No   
 I find it difficult to address     Yes   No   
 I do not know what/how to ask    Yes   No   
  
If a patient has a problem, I am unsure about therapeutic options    
          Yes   No   
 Other,      __________________  
          
 What percentage of female patients that you see do you believe have a history of 
sexual abuse? 
Please give a percentage       ________  %  
 
 Demographics 
   What is your age?    _______  Years 
   What is your gender?       Male 
       Female  
What is you profession?    
  Urologist           
   Resident urology         
   Paediatric urologist       
 Where do you work?         
   Academic (teaching) hospital      
           District general teaching hospital      
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Introduction: Sexual abuse (SA) history can be found in the backgrounds of an important fraction 
of men (8-10%) and women (12-25%). Until now there are no data about this prevalence within a 
urological patient population. 
Aim: To establish the prevalence of SA among men and women visiting a urological outpatient clinic 
and to assess their opinion on screening for SA by urologists. 
Methods: A questionnaire to identify SA was translated into Dutch, English, and Turkish, and was 
adjusted for use in men. These questionnaires were anonymously distributed among 1,016 adult 
patients attending the urological outpatient clinic. 
Main outcome measure: The self-reported prevalence of SA. Secondary outcome measures were 
data about the assailant, victim's age at the time of the abuse, if the abuse was disclosed to the 
urologist, if the urologist had asked for SA, and patient opinions on standard screening for SA in 
urological care. 
Results: A total of 878 questionnaires were returned, giving a total response rate of 86.4% 
(878/1,016). Thirty-three patients refused to participate. This resulted in 845 filled-out 
questionnaires suited for analysis (845/1,016 = 83.2%). There were more male (75.7%) than 
female respondents (21.8%); 2.1% (13/624) and 13.0% (21/161) of the male and female 
respondents reported a history of SA, respectively. Almost 42% reported a stranger as assailant. In 
nearly 90%, the SA took place before adulthood: 56.2% in childhood and 31.2% in adolescence. 
Fifteen percent of the respondents with SA had it disclosed to their urologist. More than 70%  of the 
abused respondents considered the idea to screen for SA in urological practice to be a good one. 
Conclusions: The prevalence of SA in patients seeking urological care in the Netherlands is 2.1% 
















According to large population based surveys the prevalence rate of sexual abuse (SA) in western 
society range from 12 to 25 percent for females and from 8 to 10 percent for males1,2. Several 
papers report about the association between a history of SA and specific urological complaints3-9. 
However, the prevalence of SA within a general urologic population never has been investigated. 
Noteworthy, Dutch urologist estimate the prevalence of SA in their female patient population to be 
less than 10%, which is lower than the percentages mentioned for the general population10.  
 
Aims 
The primary purpose was to determine the prevalence of a history of SA among male and female 
patients seeking general urological care. In addition, we investigated whether patients who had 
been forced to engage in unwanted sexual activities 1) had disclosed the SA to their urologist, 2) 
had been asked about SA by their urologist, 3) their own opinion with regard to standard screening 
for SA by urologists, 4) the identity of the assailant and 5) victim’s age at which the SA occurred. 
 
Methods:  
A German questionnaire to measure the prevalence of SA among females seeking gynecological care 
was translated into Dutch, English and Turkish and also adjusted for males11. From September 2008 
to December 2008  these questionnaires were anonymously distributed among 1016 adult patients 
attending the urological outpatient clinic of the HagaHospital in The Hague, the Netherlands. A 
general practitioner and a psychiatrist were on call if a respondent became distressed completing 
the questionnaire. However, no distress was reported and emergency consultations were not 
necessary. The questionnaire was available in Dutch, Turkish and English. The last two were chosen 
while these are the most frequently spoken foreign languages in The Hague. Nine participants 
requested the Turkish and seven the English version. All attending patients received a letter 
explaining the goal of the study and the content of the questionnaire. Those who didn’t want to 
participate marked “No, I don’t want to participate”. Part I included patient characteristics and two 
questions concerning a possible history of SA. The first “Have you ever been the subject of 
unwanted sexual attention such as having been propositioned, touched etc.?” was included to 
ensure that patients could differentiate between physical abuse and SA and the second “Have you 
ever been forced to have sexual activities that you did not want?” was intended to screen for SA. 
Possible answers to these two questions were “yes,” “no,” or “I don’t know.” Those who answered 
“yes” to the second question were asked to complete part II. This consisted out of five questions. 
The first was related to the first time of the SA: as a child (0–12 years), an adolescent (13–17 
years), or as an adult (18+ years). The second question disclosed the identity of the assailant: 
parent, spouse, relative, friend, or stranger and the third revealed if the patient had ever talked to 
their urologist about SA. Response options were “yes,” “no, because I did not consider the 
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information to be relevant to the urologist,” and “no, because I was afraid to talk about the subject 
with the urologist.” The fourth question was if their urologist had ever asked  them for a history of 
SA and the fifth asked patients about their opinions with regards screening for SA by urologists. 
Throughout the study period the secretaries distributed the questionnaires every day to all patients 
visiting the outpatient clinic. A small mark was left on the patient identification card to prevent 
doubles. Patients were asked to fill in the questionnaire in the waiting room and to deposit it in a 
marked and secured box. The local Research Ethics Board gave approval. 
 
Main Outcome Measure  
The primary outcome measure was the self reported prevalence of SA. The data were entered into 
and analyzed with SPSS 16.0 (SPSS Inc., Chicago, IL). Descriptive statistics were used to estimate 
the prevalence of unwanted sexual attention and activities and to examine rates of disclosure and 
screening. Frequencies were calculated for categorical data, and means and standard deviations 
(SDs) for continuous ones. Secondary outcome measures were: the number of patients who had 
disclosed the SA to their urologist, the number of patients asked for SA by the attending urologist, 
their opinions about standard screening for SA abuse by urologists, age at which SA occurred and 
the identity of the assailant. 
 
Results 
A total of 878 questionnaires were returned, giving a total response rate of 86.4% (878/1016). 
Thirty-three patients notified not to participate. This resulted in 845 filled out questionnaires suited 
for analysis (845/1016=83.2%). In correspondence with the m/f ratio in Dutch urological patients, 
there were more male respondents (75.7%) than female ones (21.8%). Unfortunately 2.5% 
(21/845) did not depict their gender identity. Thirteen out of the 624 males (2.1%) reported a 
history of SA and 21 out of the 161 females (13.0%). When asked for a broader definition of abuse 
(“unwanted sexual attention“) the prevalence was 4.1% (25/608) for the male respondents and 
16.8% (26/155) for the female ones. The mean and median age of the participating males were 
respectively 63 and 66 years versus 59 and 57 for the females (not significant). Respondents 
younger than 60 reported more often a history of SA compared to those older than 60 (24 vs 10, 
p<0.05). Two of the 34 who reported SA, did not fill out the rest of the form, so 32 completed 
forms (11 males and 21 females) could be used for further analysis. Two out of the 32 respondents 
(both females) reported more than one assailant (parent and friend, parent and stranger). Both 
respondents were placed in the group “parent”. Most respondents with SA reported a stranger as 
assailant, namely 41.9%. Compared to older ones, males under 60 accounted more often a stranger 
as assailant (85.7%) (p<0.05), while females above 60 reported more often a parent as assailant 
(Table 1). In nearly ninety percent the SA took place before adulthood: 56.2% in childhood (18/32) 
and 31.2% in adolescence (10/32), statistically not different for males/females or ages. Only 5 of 
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the 32 abused respondents (15.6%) had reported their SA history to their urologist. Half of them 
(16/32) had not given this information while they thought it was not relevant for their urologist. 
25% (8/32) had not spoken about their SA, because it was their very first visit. Three respondents 
(9.4%) wrote that they were afraid to discuss the subject. Only one patient with a history of SA 
had ever been asked for it by her urologist. 71.9% of the abused respondents (23/32) supported 
the idea to screen for SA in urological practice. This did not differ neither with regards gender 
identity (72.7% of the males; 71.4% of the females), nor for age (73.9% for ≤60 and 66.7% for 
>60). Without any argument one female participant wrote that routine screening during urological 
work up was a bad idea (Table 2). 
 












      
    Male ≤ 60 Male >60 Female ≤ 60 Female >60 Total 
What is the 
identity of the 
assailant? 
Parent 0 0 1 3 4 
0,0% 0,0% 6,2% 60,0% 12,9% 
Spouse 0 0 5 0 5 
0,0% 0,0% 31,2% 0,0% 16,1% 
Relative 1 2 6 0 9 
14,3% 66,7% 37,5% 0,0% 29,0% 
Stranger 6 1 4 2 13 
85,7% 33,3% 25,0% 40,0% 41,9% 
Total 7 3 16 5 31 
100,0% 100,0% 100,0% 100,0% 100,0% 
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This is the first report about the prevalence of a history of SA among males and females attending a 
general urologic outpatient clinic. The self-reported prevalence rate of SA by females visiting our 
urologic clinic (13.0%) corresponds to the data in other specific Dutch female populations (11-
24%)12-16. See also Table 3. The prevalence of a history of SA (2.1%) in our male respondents is 
lower than reported in international literature (8-10%), but comparable to a Dutch prevalence rate 
of approxemately 4%1,15,17. Male patients in urological outpatient clinics are relatively old. It may be 
possible that they don’t want to bring up their history of SA because of embarrassment due to the 
values of an earlier era. In addition, memory loss about events that happened a long time ago may 
play a role. Another reason can be that SA history is not recognised as being SA history. In a study 
by Holmes et al. 35% of the surveyed men did not self-define abusive childhood sexual experiences 
to be childhood sexual abuse18. According to MacMillan and co-workers there is a greater willingness 
in males and females under 60 years to report SA compared to people older than 6019. Also in our 
study there seems to be a greater willingness in males and females under 60 years to report SA 
compared to older respondents. If there was an accompanying partner, older male respondents may 
have been reluctant to bring up SA, because they never had discussed this with their partner. The 
same holds for the questionnaire. Although we created an anonymous setting, we noticed that some 
participants completed it in the presence of their partner. We also observed two partners reading 
the questionnaire aloud to the visually impaired respondent. One author even noticed a partner, 
      
    
Male ≤ 60 Male >60 Female ≤ 60 Female >60 Total 








Good idea 5 3 12 3 23 
71,4% 75,0% 75,0% 60,0% 71,9% 
Bad idea 0 0 0 1 1 
0,0% 0,0% 0,0% 20,0% 3,1% 
No opinion 1 0 3 1 5 
14,3% 0,0% 18,8% 20,0% 15,6% 
Missing 1 1 1 0 3 
14,3% 25,0% 6,2% 0,0% 9,4% 
Total 7 4 16 5 32 
100,0% 100,0% 100,0% 100,0% 100,0% 
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who wrote the answers of the respondent without asking for his opinions. Undoubtedly these 
observations distorted our study. Seventy percent of Dutch female patients are willing to fill in a 
questionnaire  about possible SA at their first visit to a urologist and nearly 70% of the Dutch 
urologist asks their female patients for a history of SA, but how many urologists ask males for SA is 
unknown10.  We suppose that urologists seldom ask their male patients for SA, but we have no data 
to support this hypothesis. While the prevalence of SA is low, one can argue that standard screening 
for SA is not necessary in male urological patients. However, this study shows that 70% of the 
urological patients with a history of SA support the idea to screen for it. SA victims report a lifetime 
history of multiple exposures to various trauma and higher levels of mental illness symptoms20. 
Sexual violence is associated with lower rates of participation in cervical cancer screening and 
increased risk of posttraumatic stress disorder and depression21-24. However, it is unknown if 
patients with a history of SA tend tot avoid urological examinations including cystoscopy. We think it 
is commendable to screen for SA before urological examinations. The importance of discussing SA 
before performing a gynaecological examination is clear. Survivors of SA rate the gynaecologic care 
experience more negatively than the controls, experience more intensely negative feelings, and 
report being more uncomfortable during almost every stage of the gynaecological examination than 
controls25. Survivors also report more  traumatic responses during the gynaecological examination, 
including overwhelming emotions, intrusive or unwanted thoughts, memories, body memories, and 
feelings of detachment from their bodies26-29. In the study of Robohm et al., 82% of the survivors 
had never been asked about a history of SA or assault by the gynaecologic care provider25. In our 
study only one of the 24 respondents was asked about a history of SA. How forthcoming patients 
are about their medical, sexual, and SA history may strongly be influenced by the level of comfort 
created by the physician taking the history. Discussing a history of SA or sexual assault with a 
patient can be very difficult30. One of  the major problems in studies on SA is the lack of agreement 
on the definition and description of SA, like child abuse, rape, or intimate partner abuse. Child abuse 
can be defined as any activity with a child before the age of legal consent for the sexual gratification 
of an adult or a substantially older child31. These activities include oral-genital, genital-genital, 
genital-rectal, hand-genital, hand-rectal, or hand-breast contact; exposure of sexual anatomy; 
forced viewing of sexual anatomy; and showing pornography to a child or using a child in the 
production of pornography. A meta-analysis shows that a history of SA is associated with lifetime 
diagnosis of multiple disorders, like seizures, gastrointestinal problems and non-specific chronic 
pelvic pain32. Another recent meta-analysis demonstrates that SA is associated with multiple 
psychiatric problems, including lifetime diagnosis of anxiety disorders, depression, eating disorders, 
PTSD, sleep disorders, and attempted suicide33. Voiding complaints like frequency, urinary 
incontinence and dysuria are also associated with SA, but a review on this topic is not available3-9. 
No literature is available about the perception of SA-victims with regard to urological examinations. 
It is reasonably to argue that genital and rectal exam or urethrocystoscopy can be more traumatic 
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to patients with a history of SA than to those without. However, further research is needed to 
examine the impact of SA on the patient’s perception of urologic examinations. Our findings support 
the recommendation that urologists should routinely screen for the possibility of SA. By addressing 
the issue, treatment of the urological disorder may improve with an understanding of underlying 
psychological issues stemming from the abuse. Victims of SA would also benefit as screening would 
afford an opportunity to disclose abuse to a trusted medical professional, resulting in a referral for 
therapy if needed. 
 
Conclusions 
The prevalence of SA in patients seeking urological care in the Netherlands is 2.1% for males and 
13.0% for females. 15% of the respondents with SA had it disclosed to their urologist. Only one 
patient with SA was asked for it by urologist. More than 70% of the sexually abused respondents 
supported the idea to screen for SA in urological practice. Almost 42% report a stranger as 
assailant. In nearly ninety percent the SA took place before adulthood: 56.2% in childhood and 
31.2% in adolescence.   
 
Table 3: Prevalence of sexual abuse among females in The Netherlands 
*7,9% (146/1845) for 872 boys and 989 girls combined. This survey mentions a three to four time 
higher prevalence among girls, but no gender specific data is given. Recalculation of a 3  times higher 
prevalence for 108 out of 989 girls versus 36 out of 872 boys gives an estimated prevalence of 

















Draijer et al. 12 Females 20-40 years 248 1054 23.5% 1990 
Lankveld et al. 13 Non-oncologic 
gynecological patients 
50 325 15.4% 1996 
Van der Hulst et al. 14 pregnant women 
(non-clinical) without 
co morbidity 
70 625 11.2% 2006 
Lamers-Winkelman 15 11-18 years old 
students 
108 * 989 * 10.9% * 2007 
Beck et al. 16 Female patients 
attending an 
university pelvic floor 
center 
42 185 22.7% 2009 
This report Female urological 
patients 
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Multiple pelvic floor complaints are correlated with 
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Introduction: The relationship between sexual abuse and urinary tract symptoms, sexual abuse 
and gastrointestinal symptoms, or sexual abuse and sexual dysfunction has been described before. 
A correlation between all these symptoms and sexual abuse has not yet been reported. 
Aims: The first aim of this study was to document the prevalence rates of reported sexual abuse in 
a large sample of female patients with complaints of the pelvic floor. The second aim was to 
evaluate the frequency of complaints in the different domains of the pelvic floor, such as complaints 
of micturition, defecation, and sexual function, in female patients reporting sexual abuse, and 
comparing these data with female patients without a history of sexual abuse. 
Methods: Female patients with pelvic floor complaints were evaluated in a tertiary referral center. 
History taking was assessed by a pelvic-floor clinician. The number of domains with complaints of 
patients with a history of sexual abuse was compared with the number of domains with complaints 
of patients without sexual abuse. 
Main Outcome Measures: The number of patients who reported sexual abuse and the frequency 
of complaints in the different domains of the pelvic floor. The number of domains of patients with a 
history of sexual abuse was compared with patients without a history of sexual abuse. 
Results: Twenty-three percent (42/185) of the patients reported a history of sexual abuse. The 
female patients with a history of sexual abuse had significantly more complaints in three domains of 
the pelvic floor (35/42) compared with the nonabused (69/143) (83% vs. 48%, p<0.001). 
Conclusions: Twenty-three percent of the female patients in a pelvic floor center evaluated by a 
pelvic-floor clinician reported a history of sexual abuse. This is comparable with the percentage of 
sexual abuse observed in the population at large. In our sample, the patients with multiple pelvic 
floor complaints (micturition, defecation, and sexual function) related to pelvic floor dysfunction 















International estimates of the prevalence of sexual abuse are high. In a review from Kellogg and the 
Committee on Child Abuse and Neglect in 2005 is suggested that each year approximately 1% of 
children experience some form of sexual abuse, resulting in the sexual victimization of 12% to 25% 
of girls and 8% to 10% of boys by 18 years of age1. Results of a national telephone survey 
conducted in 2001-2003 in the U.S.A. indicate that 1 in 59 U.S.A. adults (2.7 million women and 
978,000 men) experienced unwanted sexual activity in the 12 months preceding the survey and that 
1 in 15 U.S.A. adults (11.7 million women and 2.1 million men) have been forced to have sex during 
their lifetime2. The relationship between sexual abuse and urinary tract symptoms, sexual abuse and 
gastro-intestinal symptoms or sexual abuse and sexual dysfunction has been described in many 
articles, but it has not been quantified statistically3-11. The pelvic floor controls isolated and 
integrated functions, sustains proper anatomic relationships between pelvic visceral organs and its 
outlets, and shares the basic mechanism with various visceral organs that control their function. The 
pelvic floor, consisting of muscular and fascial components, is the binding element between these 
organs. It is also considered to be an influential factor in dysfunction and subsequently behavior of 
the genital system in both men and women12. However, literature is scarce on the topic of the 
diagnostic investigation of pelvic floor and there is a lack of uniformity in the description of the 
anatomy per se and the nomenclature of the pelvic floor13-15. A relationship between the complaints 
of micturition, defecation and sexual dysfunction related to the pelvic floor dysfunction and a history 
of sexual abuse has been suspected, but has not been previously examined or reported upon to 
date. The first aim of this study was to document the prevalence rates of reported sexual abuse in a 
large sample of female patients with complaints of the pelvic floor. The second aim was to evaluate  
the frequency of complaints in the different domains of the pelvic floor, such as complaints of 
micturition, defecation and sexual function in female patients reporting sexual abuse and comparing 
these data with female patients without a history of sexual abuse. Our hypothesis was that patients 
referred to a tertiary center with complaints of micturition, defecation and/or sexual dysfunction 
related to the pelvic floor dysfunction are more likely to have of a history of sexual abuse than 
women with complaints in fewer domains of the pelvic floor. 
 
Methods 
All female patients referred between January 2004 and November 2007 by urologists, 
gynaecologists, surgeons or gastroenterologists to our out patient pelvic floor center for pelvic floor 
evaluation due to complaints of micturition, defecation and /or sexual dysfunction possibly related to 
pelvic floor dysfunction were included. The pelvic floor clinician assessed the medical history of the 
patient.  This consisted of a pelvic floor questionnaire in which different domains of the pelvic floor 
(micturition, defecation and sexual function) were structurally evaluated. The Pelvic Floor 
Inventories Leiden (PelFIs), a validated questionnaire, was used16. At the start of the development 
58 
 
of the PelFIs, the type of sexual abuse was not specified, only a history of sexual abuse was 
recorded. Later on the PelFIs was improved addressing the nature of sexual abuse: incest, sexual 
intimidation, rape, marital rape, sexual harassment, including forcible fondling, or not (otherwise) 
specified. The PelFIs is validated in Dutch and English17. A retrospective search was performed to 
evaluate if the referring physician has documented the type of sexual abuse in the patient’s medical 
record. For the analysis patients were divided in two groups: patients with a history of sexual abuse 
(Group I) and patients without a history of sexual abuse (Group II). If a patient had at  least one of 
the following complaints related to the different domains of the pelvic floor we defined her as 
positive for that domain. The domains are the urological domain, gastro-intestinal domain and 
sexual domain (Table 1). The data were analysed using SPSS version 14. Differences in frequencies 
were evaluated using Pearson's chi-square test or Fisher's exact test when cells with less than 5 
expected subjects were present. A two-sided p-value <0.05 was considered statistically significant. 
 
Results 
A total of 185 female patients were retrospectively included and evaluated by a pelvic floor 
physiotherapist. No patients were excluded. The mean age of the population was 47.1 yr (SD 15.5 
yr). Twenty-three percent of the patients (42/185) reported a history of sexual abuse. In the total 
group of patients the mean age of the sexually abused patients (Group I) was not significantly 
different from the not sexually abused patients (Group II) (43.7 vs 48.1 ; p= 0.106). The type and 
frequency of sexual abuse are listed in Table 2. The type of abuse could not be determined in 
23.8% of the abused patients (10/42). Questions regarding sexual abuse were added in a follow up 
version of the PelFIs. In an earlier version sexual abuse was not specified by the patient, pelvic floor 
clinician or documented in the patients’ medical record by the referring physician. In the sexually 
abused group 7.2% (3/42) of the patients had complaints in one domain of the pelvic floor versus 
17.5% (25/143) in the non-abused group. Differences in two and three domains are 9.5% (4/42) in 
the abused group versus 34.2% (49/143) in de non-abused-group and 83.3% versus 48.3% (69 




A sexual abuse prevalence of 23% at our outpatient academic pelvic floor center is comparable to 
earlier published data, in which a prevalence of 4%-38% has been described3;18-24. Kellogg reported 
a sexual abuse prevalence of 12%-25%1. In a prevalence study in a gynecologic outpatient clinic of 
a large urban teaching hospital Peschers reported that one fifth of the patients (20.1%) had been 
forced to engage in sexual activities21. Many studies have shown that sexual abuse might lead to a 
variety of symptoms in one domain of the pelvic floor3-6;9-11;17,21,22;24-29. To our knowledge, this is the 
first publication about the relationship of complaints of micturition, defecation and sexual 
dysfunction related to the pelvic floor dysfunction and a history of sexual abuse. Our study 
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demonstrated a significantly higher rate of sexually abused women with complaints in the three 
domains of the pelvic floor compared to women with complaints in fewer domains. One of the 
limitations of this study is that we only included dyspareunia as a sexual dysfunction issue. In 2005 
the Pelvic Floor Clinical Assessment Group of the International Continence Society described the 
domains of the pelvic floor including also pelvic pain and pelvic organ prolaps30. Our study was 
started in 2004, so we did not include pelvic pain and a more specific definition of sexual 
dysfunction. Nor did we specify the type of sexual behavior that occurred during the abuse in genital 
penetration versus touch or forced oral sex. Another limitation of our study is that our sample is self 
selected. Therefore more patients with complaints of micturition, defecation and/or sexual 
dysfunction related to the pelvic floor dysfunction can be found in our research population. We 
believe that if this study would be performed in a urological, gynaecological, gastroenterological or 
surgical outpatient office, the difference may be even more significant, because the probability of 
selection is much lower. The fact that only 28 out of 185 of the women had only a single complaint 
could indicate  that having only a single complaint is rare. We believe that this is the result of a 
selection bias, because referrers think of a pelvic floor dysfunction sooner in patients with multiple 
pelvic floor complaints. Another limitation is that instead of studying two large cohorts, one of 
sexual abused women and non abused controls, and then looking at pelvic floor domains, we used 
two groups which are already a pathological sample; women who went to a pelvic floor clinic with at 
least one pelvic floor problem. There is no real control group since both groups have already 
pathology. Women forced to engage in oral sex with a perpetrator may have very different sexual 
problems compared to women who had forced intercourse. Additionally, a sexual abuse experience 
that includes fondling is very different from a sexual abuse that includes intercourse and can have a 
different impact for the functioning of the pelvic floor. So, analyzing sexual abuse as a homogenous 
experience, can influence the outcome of the study. The importance of discussing abuse before 
performing a gynaecological examination is clear. Survivors of sexual abuse rated the gynaecological 
care experience more negatively than the controls, experienced more intensely negative feelings, 
and reported being more uncomfortable during almost every stage of the gynaecological 
examination than the controls. Survivors also reported more trauma-like responses during the 
gynaecological examination, including overwhelming emotions, intrusive or unwanted thoughts, 
memories, body memories, and feelings of detachment from their bodies31-35. Physicians should also 
consider that any kind of gynaecological examination in these women may trigger a flashback of the 
primary situation and retraumatize the concerned women36. Farley demonstrated  a decreased 
probability of screening for cervical cancer at women who have been sexually abused, indicating 
that women who have been sexually abused tend to avoid routine gynaecological care37. The clinical 
significance of the findings in this study suggests that a holistic view  is needed in the treatment of 
pelvic floor dysfunction treatment and all domains need to be assessed in a questionnaire as early 
as possible during history taking, as was already described by Devroede38. A hypothesis for 
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complaints in more domains in the abused group could be that they are related to a general pelvic 
floor disorder. This disorder is probably related to a overactive rest tone of the pelvic floor15. For 
example, Leroi reported that patients with a history of  sexual abuse have a significantly more 
disturbed anorectal motility and a increased resting pressure at the lower part of the anal canal 
compared to non-abused patients with anismus7. The pelvic floor comprises several layers: from 
superficial to deep, the supportive connective tissue of the endopelvic fascia, the pelvic diaphragm 
(levator ani and coccygeus muscle), the perineal membrane (urogenital diaphragm) and the 
superficial layer (bulbospongiosus, ischiocavernosus and superficial transverse perineal muscles)12; 
39. The iliococcygeus, pubococcygeus and puborectal muscles make up the levator ani muscle and 
play an important role in prevention of pelvic organ prolapse and incontinence. The perineal 
membrane is a fibrous muscular layer directly below the pelvic diaphragm. The current concept is 
that the muscular contents of this layer are formed by the distal part of the external urethral 
sphincter muscle (compressor urethra and urethrovaginalis part of the external urethral sphincter). 
The bulbospongiosus and ischiocavernosus muscles of the superficial layer also have a role in sexual 
function while the superficial transverse perineal muscle has a supportive role. Pelvic floor muscle 
contraction presumably involves contraction of these muscles groups40-42. We conclude that sexual 
abuse survivors may have a dysfunction of the above mentioned muscles, giving rise to urological 
complaints, gastro-intestinal complaints and/ or sexual dysfunction.  
 
Conclusions 
Twenty-three percent of the female patients in a pelvic floor center reported a history of sexual 
abuse. In our sample, patients with multiple pelvic floor complaints related to pelvic floor 
dysfunction are more likely to have a history of sexual abuse than patients with isolated complaints. 
Further research is needed to assess the impact of pelvic floor dysfunction and sexual abuse in 


























Gastro-intestinal Domain Sexual Domain 
Urgency / frequency Frequency Dyspareunia 
Hesitation Blood loss   
Weak urinary stream Inappropriate emptying   
Intermittent urinary 
stream 
Defecation in tempi   
Straining when urinating Straining   
Residual awareness Peri-anal skin complaints   
Urinary tract infections Soiling   
Painful voiding Incontinence of stool or 
flatus 
  
  Peri-anal pruritus   




Incest 11 26.2 
Sexual intimidation 4 9.5 
Rape 3 7.2 
Marital rape 9 21.4 
Sexual harassment 5 11.9 
Unknown 10 23.8 
Total 42 100 
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Domains:  number of domains of the pelvic floor with complaints 
Abused +: number of patients with a history of sexual abuse 
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Introduction: Sexual abuse (SA) is present in about a quarter of female patients presenting with 
complaints of micturition, defecation and/or sexual function. The pelvic floor plays an important role 
in the aetiology of these complaints. 
Aim: To find out which complaints from the domains of the pelvic floor are correlated with SA. 
Methods: A case-control study in which an administered validated questionnaire the Pelvic floor 
Inventories (PeLFIs) was used to evaluate 55 patients with pelvic floor dysfunction (PFD) and 50 
controls in a tertiary referral center in Canada. Complaints of the pelvic floor of patients with and 
without SA were compared. 
Main Outcome Measures: The survey results. 
Results: Patients with pelvic floor complaints showed a significantly higher percentage of SA (22%) 
compared to the control group (2.1%) (p=0.008). In the PFD group a history of SA correlated 
significantly with complaints of constipation (p<0.01), sexual dysfunction (p<0.01) and 
urgency/frequency (p<0.01). 
Conclusion: In a pelvic floor population, constipation and/or sexual dysfunction and/or 
























Meta-analysis show negative effects of (childhood) sexual abuse (SA) on psychological and physical 
wellbeing. A meta-analysis shows that a history of SA is associated with lifetime diagnosis of 
multiple disorders, like seizures, gastrointestinal (GI) problems and non-specific chronic pelvic pain1. 
Another meta-analysis demonstrates that SA is associated with multiple psychiatric problems, 
including lifetime diagnosis of anxiety disorders, depression, eating disorders, post-traumatic stress 
disorder (PTSD), sleep disorders and attempted suicide2. Studies have shown the relationship 
between SA and complaints of micturition, defecation, and/or sexual functioning3-7. The pelvic floor 
plays an important role in the prevention of these complaints8-11. If the pelvic floor is no longer 
capable of maintaining one of these functions, this is referred as a pelvic floor dysfunction (PFD). 
According to large population-based surveys, the prevalence rate of SA in western society ranges 
from 12 to 25% in women and from 8 to 10% in men6;12,13. These estimates of the prevalence of SA 
in the population differ widely due to the use of varying definitions (e.g. childhood sexual abuse 
versus lifetime, unwanted versus forced) and methodology (e.g. interview- versus questionnaire- 
versus informant studies). In our university pelvic floor center, 23% of the women reported a 
history of SA14. We also discovered that synchronic complaints in multiple domains of the pelvic floor 
are correlated with SA14. The aim of this study is to find out what complaints from the domains of 
the pelvic floor are correlated with SA. Furthermore we wondered what percentage of a sample of 
patients with pelvic floor dysfunction has a history of sexual abuse.  
 
Methods 
A case-control study was chosen to compare patients with PFD with controls. Participants were 
consecutively selected for inclusion at an Incontinence and Pelvic Pain Clinic (IPPC). At the IPPC, all 
women eligible for pelvic floor physiotherapy were considered for the patient group, regardless of 
the domain in which they experienced symptoms. Before inclusion, patients with pathology other 
than complaints related to PFD were excluded. Healthy volunteers, without a treatment-whish for 
the above mentioned pelvic floor-related symptoms and without medication for PFD were considered 
eligible for inclusion in the control group. These volunteers, visiting the practice for other reasons, 
were recruited through written advertisement and by word of mouth. The women in the patient 
group were informed about the study by a pelvic floor physiotherapist and were asked to 
participate. This study was carried out using the Pelvic Floor Inventories Leiden (PeLFIs) for women, 
a 149-item questionnaire which has been validated in Dutch and English15,16. It is an administered 
questionnaire, used to obtain accurate information about the different domains of the pelvic floor. 
The questions are relating to the domains of: general health, prolapse, lower urinary tract 
symptoms (LUTS), defecation, obstetric information, pelvic floor pain and sexual function. One 
question in the sexual function-domain is about SA. During the validation of the PeLFIs in English, it 
was distributed to 55 women with complaints of prolapse, bladder, bowel dysfunction, sexual 
function and/or pelvic floor pain and to 49 healthy volunteers in Canada. All participants provided 
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written informed consent. Approval of this study was obtained by the University of Manitoba, 
Canada. Data analysis was performed using SPSS release 18 (SPSS Inc., Chicago, IL, USA). 
Frequencies were used to estimate the prevalence of sexual abuse and to examine the types of 
abuse. Means of numerical demographic values were compared with the independent T-test. 
Bivariate associations between the groups and the type of answers were calculated using the 
Pearson chi-square procedure. We assessed correlation with al types of abuse and the different 
domains of the pelvic floor, using Pearson’s correlations. Two-sided p values<0.05 were 
considered statistically significant. 
 
Results 
A total of 105 women completed the PeLFIs of whom 55 were patients known with complaints 
due to a PFD and 50 controls. The mean age of patients was 54.3 (SD 15.32) this was perfectly 
comparable with the control group, which had a mean age of 54.0 (SD 15.33). The body mass 
index (BMI) did not differ significant between the case and control group. In the patient group 
the use of medication was statistically higher than in the control group 80.0% and 63.3% 
respectively (p=0.05), yet there were no significant difference in the use of anti-depressants 
between the two groups (Table 1). The prevalence of abuse (sexual, physical or mental) in the 
patient group is 25.5%, which is significantly higher than the 2.0% prevalence in the control 
group (p=0.002). Equally, the patient group showed a significantly higher percentage of SA 
compared to the control group, 22% versus 2.1% (p=0.008). Because it was possible to mark 
multiple answers, the majority of the abuse victims (64.3%, n=9) reported to have experienced 
more than one type of abuse. Two patients even noted to have experienced all the types of 
abuse mentioned in the questionnaire. The reported types of abuse are listed in Table 2. Of the 
patients that reported to have experienced a form of abuse, 53.3% stated to have received help 
to deal with it. In fact 85.7% of them confirmed to have been able to deal with their 
experience(s). However, 50% of the patients with an abuse history stated that they would like 
to receive help to deal with their past. Because we hypothesized that sexual abuse would have 
more impact on PFD than physical- or mental abuse, we analyzed the correlation with the 
different domains of the pelvic floor for all the types of abuse separately. De domain 
constipation correlated significantly with SA in all its forms (mean r=0.28, p<0.01), there was 
no correlation between constipation and physical violence or metal cruelty. In the same way, the 
domain about sexual dysfunction correlated with SA (r=0.32, p<0.01), and not with physical- of 
mental abuse (Table 3). Within the domain obstructive micturition (urgency/frequency), the 
questions ‘do you feel urge to urinate when you hear water running?’ and ‘do  you feel the urge 




























































Do you have negative 
experiences in the past 












Incest 6 (12) 0 
Rape 5 (10) 0 
Sexual intimidation 6 (12) 1 (2,1) 
Marital rape 2 (4) 0 
Sexual harassment 5 (10) 1 (2,1) 
Sexual abuse (total) 11 (22.0) 1 (2,1) 
Physical violence 5 (10) 0 
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 Table 3: Correlation of PFD domains and sexual abuse 
 
 
* correlation is statistically significant 
 
Discussion 
This study is the first case-control study to evaluate SA and SA-related complaints in a Canadian 
population with patients referred to a tertiary clinic to be treated for their complaints related to 
pelvic floor dysfunction. The prevalence of SA in the case group was 22% versus 2% in the 
control group p<0.05). In a Dutch outpatient population of female patients referred for academic 
pelvic floor physiotherapy, the prevalence of SA was 23%14. So the prevalence in this Canadian 
PFD group is comparable to another PFD population. In urology practice SA was seen in 13% of 
the female patients17. In the gynaecology practice, SA is seen in 15-20% of the patients. In 
patients with functional gastroenterological complaints these numbers are even higher with 30-
56%18-22. Equally important are the sexual dysfunctions, which are associated with SA experience 
in 21 up to 95% of the patients23-25. Chronic pelvic pain is highly correlated to SA as well (up to 
55%)26. We made use of a validated questionnaire (PeLFIs) which has been proven to be a 
reliable instrument in obtaining information about abuse27. Confounding is a limitation in all case-
control studies. As with all case-control studies we measured a retrospective exposure (SA), 
although the exposure is random in the cases. Use of medications can be a confounder. Several 
medications can have an influence on symptoms of the bladder, bowel or pain perception. It is 
possibly that because controls with medication of symptoms of the pelvic floor were excluded, the 
PFD group significantly used more medications (p=0.05). Age and BMI are comparable, and the 
controls are acquired in the same population as the cases (patients visiting IPCC for other 
 




Prolaps -0.006 0.958 
Micturition 0.167 0.118 
Urinary incontinence 0.262* 0.013 
Obstructive micturition -0.044 0.682 
Defecation 0.070 0.512 
Fecal incontinence 0.179 0.093 
Constipation 0.194 0.068 
Pelvic floor pain 0.054 0.614 
Sexual dysfunction 0.312* 0.003 
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reasons). So these are no confounders. Because of the extremely low prevalence of SA in the 
control group (2%), we assume a selection-bias. It is possible that controls with SA avoid a 
voluntarily inquiry about complaints related to SA, or were excluded because of the use of pelvic 
floor symptom related medication. The numbers used in both groups were sufficient to reach 
statistical power. However, correlations between 0.25 and 0.50 indicate that the strength of the 
correlation is weak to moderate, even though the existence of the correlation has proven to be 
statistically significant. The pelvic floor comprises several layers, including the pelvic diaphragm 
(levator ani and coccygeus muscles) and the urogenital diaphragm. Each diaphragm has its own 3D 
shape and position with regard to the internal pelvic organs. The urogenital diaphragm consists of a 
deep layer, the perineal membrane, and a superficial layer, consisting of the bulbospongiosus 
muscle and the ischiocavernosus muscle. The levator ani muscle is made up of the iliococcygeus, 
pubococcygeus, and puborectalis muscles. Together with the urethral and anal sphincters, these 
muscles play an important role in preventing complaints of micturition, defecation, sexual 
dysfunction, prolapse and/or pelvic floor pain. The development of one of these complaints is 
referred to PFD11;28-32. When explaining urological symptoms correlated to SA, it has been 
hypothesized that patients with PFD have voiding difficulties due to a higher tone at rest of the 
pelvic floor11;33,34. Many of them have episodes of obstructive urinating complaints. As in benign 
prostate hyperplasia (BPH), long-lasting bladder outlet obstruction (BOO) can lead to overactive 
bladder symptoms35. Overactive bladder (OAB, urgency syndrome) is defined as: urinary urgency, 
usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the 
absence of urinary tract infection (UTI) or other obvious pathology33. Obstruction-induced changes 
in the bladder are of two basic types. First, the changes that lead to detrusor instability or decreased 
compliance are clinically associated with symptoms of frequency and urgency. Second, the changes 
associated with decreased detrusor contractility are associated with further deterioration in the force 
of the urinary stream, hesitancy, intermittency, increased residual urine, and (in a minority of cases) 
detrusor failure36. Pelvic floor physiotherapy can be used to treat pelvic floor related BOO and OAB 
symptoms37. In this study cases with SA have significantly more complaints of urgency and 
frequency. When confronted with a patient reporting a SA history, while dealing with PFD and OAB, 
a purely symptomatic treatment of the complaints may not be sufficient to help the patient. In a 
randomised trial in anxious, depressed and phobic patients psychotherapy reduced complaints of 
OAB (urgency, incontinence and nocturia) significantly better than bladder drill or 
pharmacotherapy38. This suggests that psychopathology itself has an influence on the bladder or 
pelvic floor or both. This suggestion is proven in sexual-abuse-related gastro-intestinale complaints. 
Douglas Drossman, an expert in sexual-abuse-related gastro-intestinale complaints, wrote an 
extended review explaining the influence of SA and post-traumatic stress disorder on GI-related 
complaints. In summary: although abuse history may be present across all diagnostic categories, 
more severe abuse seems to occur in patients with functional GI disorders. The pathophysiological 
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features that explain this association relate to stress-mediated brain-gut dysfunction and can range 
from altered stress-induced mucosal immune function to impaired ability of the central nervous 
system to downregulate incoming visceral or somatic afferent signals39. In this context one can 
assume that in this group of patients pelvic floor physiotherapy will not alter complaints 
constipation, but successful effect of pelvic floor physiotherapy with biofeedback included in patients 
with SA and constipation is reported40. This in contrast to surgery of the colon, which in patients 
with a history of SA and slow-transit constipation, seems to be less successful41. Drossman 
postulates a biopsychosocial treatment approach to better treat GI related complaints after PTSD 
and/or SA. The relation between sexual dysfunction after SA is best analysed is the Boston Area 
Community Health (BACH) Survey. It’s a community-based epidemiologic study of urologic and 
sexual symptoms and risk factors in a racially/ ethnically diverse random sample of women aged 
30–79 (n=3,205 women). Although abuse history was not significantly associated with likelihood of 
sexual activity. In this large sample, SA was significantly and positively associated with sexual 
dysfunction after adjusting for covariates (including depression). Analyses of the six FSD domains 
showed that the relationships were strongest for pain and satisfaction42. In a sample of 150 women 
with dyspareunia Leclerc and co-workers found a significant relation with SA and dyspareunia and a 
relation with SA and sexual dysfunction7. These are good explanations why in our PFD sample 
sexual dysfunction is significantly correlated with SA.  In a large meta analysis, SA is correlated to 
pelvic pain with an odds ratio of 2.75 (95% CI 1.73-4.30)1 . In our results this correlation was not 
reproduced. The above mentioned confounding or bias can be an explanation for the lack of 
correlation. With this study we confirm that sexual abuse is an important factor in the development 
of various complaints related to PFD. We are convinced that inquiring about sexual abuse should be 
routine in the history taken by health care providers, especially when patients present with 
complaints related to PFD and before physical examination is performed or treatment starts. When a 
history of sexual abuse is confirmed, more targeted therapies may have to be used. A combination 
of pelvic floor physiotherapy and psychological treatment may be necessary in addition to better 
treat PFD after SA. A randomised clinical trial in patients with PFD and SA comparing pelvic floor 
physiotherapy alone versus pelvic floor physiotherapy with psychological treatment should be 
performed to further explore this topic. 
 
Conclusion 
Based on our case-control study we conclude that female patients with complaints of pelvic floor 
dysfunction report significantly more often a history of SA compared to controls. In our sample, SA 
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Introduction: The relationship between sexual abuse and urinary tract symptoms has been 
described for urgency, frequency and nocturia.  
Aims: To investigate if other urological complaints in females, like urinary tract infections, 
incontinence, voiding complaints and lower abdominal pain are also are correlated with a history of 
sexual abuse (SA) and to measure the prevalence of sexual abuse in our urological patient 
population, using a clinical case control study. 
Methods: 1383 female patients of 18-years or older visiting our outpatient urological university 
clinic were asked to fill out a questionnaire evaluating referral indications and urological complaints. 
The questionnaire consisted out of two parts. The fist was designed to collect data about 
demographic characteristics and medical history. The second part included referral indications, the 
urological complaints and a possible history of SA. The sample was divided into two groups: those 
with and those without a history of SA.  
The Outcome Measures: I. The comparison of the frequency of voiding complaints, urinary tract 
infections (UTI’s), lower abdominal pain, hematuria and incontinence in respondents with and 
without SA. II. The prevalence of SA in female patients presenting at our university urological 
outpatient clinic. III. The number of urological symptoms presented at the time of referral by 
respondents with a history of SA compared the non-abused. 
Results: 436/1383 (32%) patients were willing to participate. 304 (70%) questionnaires were 
properly filled in. The reported prevalence of sexual abuse was 17% (51/304). More than half of the 
females with a history SA presented with voiding complaints (32/51 p=0.18), incontinence (31/51 
p=0.10) and urinary tract infections (27/51 p=0.22). However, comparing the data of respondents 
without SA we found no significant differences with regards specific complaints. Patients with SA 
report more symptoms than those without (Armitage’s trend test 0.14 (p=0.004) for 4 complaints or 
more).  
Conclusions: No significant correlation between SA and voiding complaints, incontinence nor lower 
abdominal pain was found. The prevalence rate of SA in female patients visiting our university 
urological outpatient clinic was 17%. These abused females mentioned more synchronous 












Sexual abuse (SA) is defined by International Society for the Prevention of Child Abuse and Neglect 
as ”a social and medical problem in which a child under the age of consent is involved in an act 
resulting in sexual satisfaction of an adult or connivance of such an act”1. The frequency with which 
children are exposed to sexual advances from adults varies according to the definition of abuse, the 
age range studied, and the methods of ascertainment. The prevalence of SA is estimated to be 12% 
to 25% for females and 8% to 10% for males2. In 2007, for the first time in a large cohort study, 
SA was causally related with urinary urgency, frequency and nocturia for males and females, using 
the Hill-criteria (1965) for proving causality3,4. Before and after this publication several investigators 
found an association between a history of SA and urological complaints33;5-13. Voiding complaints, 
dysfunctional voiding, urgency and frequency were mentioned to be correlated with SA most 
frequently. Several studies found no relation with urinary tract infections6;14. Recently we established 
a correlation between synchronic complaints in multiple domains of the pelvic floor and a history of 
SA15. In this study we compare female patients visiting a urological out patient clinic with and 
without a history of SA. We investigated if the abused patients report more or less voiding 
complaints, UTI’s and lower abdominal pain than those without SA. In addition we established if the 
SA-prevalence in female patients visiting our out patient urological clinic was comparable to the 
percentage of 22.7% found in females visiting our university outpatient pelvic floor center15. 
Because we hypothise that SA can lead to pelvic floor dysfunction (PFD) and PFD can give several 




Over a period of 2.5 years a consecutive series of 1383 new female patients of 18-years or older 
visiting our outpatient urological university clinic were asked  to fill out a self-administered 
questionnaire evaluating referral indications and urological complaints (see Appendix). The 
construction of the database and the self-administered questionnaire were approved by the local 
Institutional Ethics Committee. It was conducted by the principle investigator (HWE, a urologist-
sexologist) to evaluate female sexual dysfunction16,17. All females received a letter explaining the 
objectives of the study and were kindly invited for collaboration. The self administered questionnaire 
consisted of two parts. The first collected data about demographic characteristics and medical 
history, the second part included referral indications, the urological complaints, sexual dysfunction 
and a possible history of SA. If relevant, patients were allowed to mention more than one reason for 
referral. A retrospective database study was performed to identify two groups: those with (cases) 
and those without a history of SA (controls). Comparisons between proportions were made using 
Pearson’s chi-square test or Armitage’s trend test; continuous variables were compared by student’s 
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t-test and, where appropriate, analysis of variance (ANOVA). Differences were considered 
significant when the two-tailed p-value was <0.05. Data analysis was carried out using SPSS for 
Windows version 16.0.1 (SPSS, Inc., Chicago, IL). The outcome measures were: I. The 
comparison of the frequency of voiding complaints, UTI’s, lower abdominal pain, hematuria and 
incontinence in respondents with (cases) and without SA (controls). II The reported percentage of 
female patients presenting at our university urological outpatient clinic with a history of SA. III. 
The number of urological symptoms presented at the time of referral by respondents with a 
history of SA. 
 
Results 
After reading the letter explaining the objectives of the study 436/1383 patients (32%) were 
willing to participate. All 436 gave written informed consent, 304 (70%) questionnaires were 
properly filled in. I. More than half of the females with SA presented with voiding complaints 
(32/51, 63%, p=0.18), incontinence (31/51, 61%, p=0.10) and urinary tract infections (27/51, 
53%, p=0.22). However, comparing the data of respondents without SA: voiding complaints 
(133/253, 53%), incontinence (122/253, 48%) and urinary tract infections (110/253, 44%) we 
found no significant differences with regard to specific complaints. Considering lower abdominal 
pain (20/51, 39%, p=0.16), hematuria (17/51, 33%, p=0.13) and colic pain (7/51, 14% p=0.98) 
we also found no significant differences between the two groups. See Table 1. II. Fifty-one 
respondents confirmed SA. This means that 17% (51/304) of the new female patients visiting our 
outpatient urological reported a history of SA. III. Using the Armitage’s trend test (0.14, p 
=0.004) to compare the reported the total number of urological complaints as reason for referral 
to the urologist, shows that patients with SA significantly report more synchronous complaints as 
reason for referral. See Table 2.  
 
Discussion 
The 17% prevalence rate of SA in females visiting our urologic outpatient university clinic 
corresponds to the percentages found in other specific populations in the Netherlands (10,9% - 
23,5%), meaning that this percentage of cases with SA is comparable with SA in other Dutch 
populations15;18-22. The populations and prevalences are listed in Table 3. In a previous study we 
found out that in an inquiry before the first visit to the urologist, 70% of the patients with a 
history of SA disclosed it23. The question asked in the questionnaire, "Did you have negative 
sexual experiences in the past" is of course not equal to "did you experiences sexual abuse in the 
past", but in the Dutch language it is considered to be similar. This is confirmed by the responses 
of patients: all patients admitted abuse, and 13 out of 14 patients described the type of negative 
sexual experience as sexual abuse23. In this sample of patients, most with urological complaints, 
we found an association between a history of SA and urological complaints, namely a higher  
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percentage of voiding complaints, incontinence and urinary tract infections in the SA group 
compared to the controls, but the differences were not significant. Several authors found a relation 
between SA and urological complaints, some didn’t. These studies are listed in Table 4. Despite the 
pre-existing urological complaints in both groups, patients with a history of SA reported significantly 
more synchronous urological complaints as reason for referral. Perhaps PFD is an explanation for 
the synchronous urological complaints. Davila et al reported significant more pelvic floor related 
urological complaints like dribbling, slow urinating stream and stress incontinence9. In the study 
from Link et al, in which a causal relation between sexual abuse and overactive bladder (OAB) was 
proven, a short review of the biological pathway was given3. They summarize that anxiety and 
behavioural responses to stress involve complex neural circuits and multiple neurochemical 
components. Acute and chronic stress due to abuse can alter these circuits, their neurochemical 
components, and bladder function24,25. In animal models stress changes bladder histology en 
physiology26-30. Link et al also mention a role for corticotrophin-releasing factor (CRF), a primary 
neurotransmitter expressed by neurons within the central stress network3. CRF is expressed by 
neurons within the pontine micturition center and within regions in the spinal cord that form part of 
the micturition reflex pathway31,32. This assumes that CRF influences bladder function. Besides the 
above mentioned biological pathways, in concordance with Davila’s observation of pelvic floor 
related urological complaints, we hypothise that pelvic floor dysfunction (PFD) is another link 
between SA history and voiding complaints. The pelvic floor is known to be an integrated structure, 
influenced by psychological and physical causes. A higher prevalence of synchronous multiple pelvic 
floor complaints, like micturition, defecation and sexual pain, are seen in patients with sexual abuse 
history33. The pelvic floor comprises several layers, including the pelvic diaphragm (levator ani and 
coccygeus muscles) and the urogenital diaphragm. Each diaphragm has its own 3D shape and 
position with regard to the internal pelvic organs. The urogenital  diaphragm consists of a deep 
layer, the perineal membrane, and a superficial layer, consisting of the bulbospongiosus muscle and 
the ischiocavernosus muscle. The levator ani muscle is made up of the iliococcygeus, 
pubococcygeus, and puborectalis muscles. Together with the urethral and anal sphincters, these 
muscles play an important role in preventing complaints of micturition, defecation, sexual 
dysfunction, prolapse and/or pelvic floor pain. The development of one of these complaints is 
referred to as PFD34. It has been hypothesized that patients with PFD have voiding difficulties due to 
a higher tone at rest of the pelvic floor35-37. Many of them have episodes of obstructive urinating 
complaints. As in benign prostate hyperplasia, long-lasting bladder outlet obstruction (BOO) can 
lead to OAB symptoms38. Obstruction-induced changes in the bladder are of two basic types. First, 
the changes that lead to detrusor instability or decreased compliance are clinically associated with 
symptoms of frequency and urgency. Second, the changes associated with decreased detrusor 
contractility are associated with further deterioration in the force of the urinary stream, hesitancy, 
intermittency, increased residual urine, and (in a minority of cases) detrusor failure39. Pelvic floor 
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physiotherapy can be used to treat pelvic floor related BOO and thus relieving OAB symptoms40. 
Unfortunately randomised studies describing improvement of urological complaints in SA survivors 
treated with pelvic floor physiotherapy are not available. Still, we are convinced that SA can lead to 
PFD (e.g. pelvic floor overactivity) resulting in BOO, resulting in voiding symptoms and later on in 
storage symptoms (OAB). This suggest that functional complaints as dysfunctional voiding, 
incontinence and urgency will be more often associated with a SA-history than complaints with a 
clear cut aetiology such as hematuria or colic pain. Our Pelvic Floor Research Group reported about 
the correlation between synchronic pelvic floor complaints in multiple domains of the pelvic floor and 
SA15. In that cohort several patients did not have any urological complaints, but had difficulties with 
defecation, sexual dysfunction and/or chronic pains; in other words not all patients with a history of 
SA necessarily  have urological complaints. In this study one patient with SA was referred because 
of an abnormal finding on ultra sound or CT scan, but had no urological complaints. A recent study 
including 238 patients with micturition, defecation and/or sexual problems, showed that 72% had an 
elevated pelvic floor rest tone36. As much as 56% of them had complaints in three domains of the 
pelvic floor. This also indicates that a history of SA can reveal itself in other, non-urological 
complaints. This study has several limitations. Confounding is a limitation in all case-control studies. 
As with all case-control studies we measured a retrospective exposure (SA), although the exposure 
is random in the cases and the controls are from the same base population. A possible confounding 
are underlying psychiatric diseases, which were not mentioned by the cases or controls or use of 
medications which are not mentioned. Some medications can mask certain urological complaints. A 
bias in this database is the definition of voiding complaints. The database and inclusion of patients 
was started before the publication of Link at al in 2007, in which urgency, frequency and nocturia 
were causally related to SA3. In our database urgency, frequency, nocturia and other voiding 
complaints are all grouped together. An attempt to redefine voiding complaints in the database by 
separating urgency, frequency and nocturia was not successful, because the type of voiding 
complaints was not specified in the questionnaire. This is the major bias of this study. Another bias 
is selection bias, because of a 32% response rate, is possible that a lot of patients with sexual abuse 
chose not to respond, what can alter the outcome, introducing a self selected sample. Those who 
responded may have been different from non-responders, making it difficult to generalize our 
findings to the entire Dutch female urological patient population. Because our prevalence of SA is 
comparable to other Dutch populations, as mentioned in Table 3, introduction of a self selected 
sample is less probable. Also, the use of a self-administered non-validated questionnaire is a 
limitation. There are several possible explanations for the low participation rate of 32%. A major 
part of the patients who were willing to participate may have been embarrassed by the content of 
the questionnaire. In addition, subjects had to be actively recruited by the urologists and residents. 
In practice, each new female patient had to be asked if she had received the letter explaining the 
objective of the study. While some females expressed themselves negatively with regards the 
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content of the study, the recruitment was not always adequately done by all the involved doctors. 
Undoubtedly, this has contributed to the relatively low participation rate. While they might be 
distracted, embarrassed, or feel compelled to complete it, we asked the participants to fill out the 
questionnaire at home and not during their appointment in the hospital. So, they were asked to 
return it by mail or to hand it over at the second visit. The latter again required a proactive attitude 
of the urologists and residents. This means that probably not all patients who had filled out the 
questionnaires were asked to deliver it properly. It would have been better to “overshoot” the 
number of distributed questionnaires to collect a lager sample. In our sample, twenty patients 
mentioned no urological complaints at all. They were referred because of abnormalities found on 
ultrasound imaging or CT-scan. One out of these twenty mentioned a history of SA. One of the 
major problems in studies on SA is the lack of agreement on the definition and description of SA, 
like child abuse, rape, or intimate partner abuse. Women forced to engage in oral sex with a 
perpetrator may have very different pelvic floor problems compared with women who had forced 
intercourse. Additionally, a sexual abuse experience that includes fondling is very different from a 
sexual abuse that includes intercourse, and can have a different impact for the functioning of the 
pelvic floor. So, analysing sexual abuse as a homogenous experience can influence the outcome of 
this study. Patients with SA reported more synchronous complaints as reason for referral than 
patients without SA. We think that PFD gives a range of urological complaints (voiding complaints 
and storage complaints), explaining the larger  number of synchronous urological complaints per 
person in the SA-group. One may hypothesize that a large number of urological complaints per 
person in a female patient points to a higher chance of a history of SA. In our opinion urologist 
should always ask their patients for SA. By addressing the issue, treatment of the urological disorder 
may improve with understanding of underlying psychological en physical issues stemming from the 
abuse. Multiple complaints as reason for referral and pelvic floor dysfunction are indicative for a 
history with SA and should alert the urologist to ask for it. 
 
Conclusions 
No significant correlation between SA and voiding complaints, incontinence nor lower abdominal 
pain was found. The prevalence rate of SA in female patients visiting our university urological 
outpatient clinic was 17%. These abused females mentioned more synchronous complaints as 










Table 1: Reported complaints as reason for referral in the patients with SA compared to 
those without SA 
 
SA+ = patients with sexual abuse history, SA- = patients without sexual abuse history,  
p = p-value 
 
  Table 2: Number of complaints reported as reason for referral to the urologist 
 
 
SA + patients with sexual abuse, SA – patients without sexual abuse. This table shows that the 
patients with SA report more symptoms than those without (Armitage’s trend test 0.14 (p=0.004) for 




















Voiding complaints 32 63% 133 53% 0.18 
Incontinence 31 61% 122 48% 0.10 
Urinary tract infections 27 53% 110 44% 0.22 
Abdominal pain 20 39% 74 29% 0.16 
Hematuria 17 33% 59 23% 0.13 
Colic pain 7 14% 35 14% 0.98 












0 1 2.0% 19 7.5% 20 6.6% 
1 16 31.4% 75 29.6% 91 29.9% 
2 11 21.5% 74 29.3% 85 28.0% 
3 7 13.7% 46 18.2% 53 17.4% 
4 8 15.7% 25 9.9% 33 10.9% 
5 5 9.8% 12 4.7% 17 5.6% 
6 3 5.9% 2 0.8% 5 1.6% 






























* 7,9% (146/1845) for 872 boys and 989 girls combined. This survey mentions a three to four time higher 
prevalence among girls, but no gender specific data is given. Recalculation of a 3 times higher prevalence for 
108 out of 989 girls versus 36 out of 872 boys gives an estimated prevalence of 10,9% for girls only. 
 







Prevalence Year of 
publication 
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al.20 
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70 625 11.2% 2006 
Lamers-
Winkelman 21 
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108* 989* 10.9%* 2007 
Beck et al.15 Female patients 
attending an university 
pelvic floor center 
42 185 22.7% 2009 
Beck et al.22 Female patients 
attending a urological 
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21 161 13.0% 2011 
Beck et al. Female patients 
attending an university 
urology clinic 
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Date of birth: 
Do you have a partner:     Yes   No    
How many children do you have: 
Do you smoke?     Yes   No    
 
Do you have: 
* Vascular or heart problems   Yes   No   
* High blood pressure    Yes   No   
* Diabetes     Yes   No   
* Neurological complaints   Yes   No   
* Psychiatric complaints   Yes   No   
 
Do you menstruate?    Yes, regularly 
      Yes, but not regularly 
      No, I haven’t had a period since a few months 
     No, I haven’t had a period for more than a year 
 
 Did you have negative sexual experiences (sexual abuse) in the past?   
       Yes   No   
 Would you be willing to provide some more information about this? 




What medication do you currently use? 
__________________________________________________________________ 
 










Urological complaints (more than one urological complaint can be filled) 
 
Pain in the region of the kidney?   Yes   No   
 
Blood in urine?      Yes   No   
 
Microscopic (not visibly red)    Yes   No   
 
Macroscopic (bloody urine)    Yes   No   
  
Urinary tract infection(s)    Yes   No   
 
Voiding complaints     Yes   No   
 
Incontinence      Yes   No   
 
Abdominal pain     Yes   No   
 
Abnormalies on radiological examination       
       Yes   No   
 
Refferd by other physician to the urologist, but no urological complaints  
       Yes   No   
 

















































































Sexual abuse and over active bladder:  
adding the pelvic floor pathway to the sexual abuse  

























Based on:  
Beck JJH, Nicolai MP, Voorham- Zalm P, Pelger RCM, Elzevier HW Sexual abuse and over 






Introduction: We review evidence linking pelvic floor dysfunction (PFD) to the current concept of 
sexual abuse (SA), overactive bladder (OAB) and corticotrophin releasing factor (CRF). 
Methods: We review the literature and add the pelvic floor pathway to the current Klausner-Steers 
model for emotional influence on the bladder.  
Results: CRF is expressed in areas of the central nervous system that response to stress and is 
increased during anxiety and after SA. CRF is expressed in areas of the central nerve system that 
control voiding and response to stress. Epidemiological and case control studies reveal an 
association between SA and PFD. PFD is related to long-lasting bladder outlet obstruction (BOO), 
which can lead to OAB. 
Conclusions: PFD after SA is another link between the relation of SA and OAB. Besides CRF and 
OAB as a therapeutic target, maybe pelvic floor physiotherapy can improve OAB after SA. We add 



























The Pelvic Floor and Sexuality Research Group at the department of urology at Leiden University 
Medical Center, the Netherlands, investigates pelvic floor function and dysfunction in relation to 
urological, sexual and pelvic floor related complaints. We review evidence linking pelvic floor 
dysfunction (PFD) to the current model of sexual abuse (SA), overactive bladder (OAB) and 
corticotrophin releasing factor (CRF). Sexual abuse (SA) is defined by International Society for the 
Prevention of Child Abuse and Neglect as ”a social and medical problem in which a child under the 
age of consent is involved in an act resulting in sexual satisfaction of an adult or connivance of such 
an act”1. The frequency with which children are exposed to sexual advances from adults varies 
according to the definition of abuse, the age range studied, and the methods of ascertainment. The 
prevalence of SA is estimated to be 12% to 25% for females and 8% to 10% males2. A meta-
analysis shows that a history of SA is associated with lifetime diagnosis of multiple disorders, like 
seizures, gastrointestinal problems and non-specific chronic pelvic pain3. Another recent meta-
analysis demonstrates that SA is associated with multiple psychiatric problems, including lifetime 
diagnosis of anxiety disorders, depression, eating disorders, post-traumatic stress disorder (PTSD), 
sleep disorders, and attempted suicide4. The reported prevalence of SA-history in the urological 
population varies from 2% for males to 13% for females5. Selection bias and recall bias are 
mentioned; therefore more studies are necessary to measure the exact prevalence of SA in urologic 
patient populations. In 2004 a biological model explaining the emotional influence on the bladder 
through the CRF-OAB-pathway was presented by Klausner and Steers6. Their model is shown in 
Figure 1. It was until 2007 that SA was causally related to OAB, using the Hill-criteria7,8. We add the 
role of PFD to the current available Klausner-Steers model (Figure 2). OAB is defined as: urinary 
urgency, usually accompanied by frequency and nocturia, with or without urgency urinary 
incontinence, in the absence of urinary tract infection (UTI) or other obvious pathology9.  
 
Klausner-Steers model6 
Stress and anxiety are intimately associated with bladder function. The extensive neural networking, 
multilevel inputs and reciprocal innervation involved in the control of bladder function suggest a 
multifactorial etiology6. CRF, a peptide synthesized in neurons of the paraventricular nucleus (PVN) 
of the hypothalamus, has been found to be a key regulator of the endocrine, behavioral, autonomic 
and immune responses to stress6. After its release from the hypothalamus, CRF triggers the release 
of adrenocorticotropic hormone (ACTH) in the pituitary. ACTH, in turn, stimulates the release of the 
stress steroid, cortisol, from the adrenal cortex. In this manner CRF acts as a hormone, triggering 
the peripheral stress response also known as the “hypothalamic-pituitary-adrenal (HPA) axis”. CRF 
also acts directly in the central nervous system as a neurotransmitter. Neurons in the brain 
expressing CRF project to critical areas that control the central stress response. These areas include 
the locus ceruleus - an area containing noradrenergic neurons and important in the regulation of the 
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flight or fight response, the dorsal raphe nucleus - an area rich in serotonin and potentially 
important in the pathogenesis of major depression, the central nucleus of the amygdale - a relay 
center for emotional stress and visceral pain, and the hippocampus - a region in memory 
processing6. In mammalian species CRF binds to 2 cyclic adenosine monophosphate coupled 
receptors, CRF-R1 and CRF-R2. CRF-R1 is prominent in the limbic regions, and CRF-R2 is more 
widely distributed in the brain and spinal cord. CRF appears to be the endogenous ligand for CRF-R1 
as it has 10-fold greater binding affinity for this receptor than for CRF-R2. Acute and chronic stress 
produces significant increases in CRF mRNA in Barrington’s nucleus, the region that controls 
micturition. Moreover, electrical stimulation of these areas of the brain excites or inhibits bladder 
activity. CRF also is important in the control of micturition at the level of the spinal cord and may be 
important in sensory processing of painful bladder stimuli. Patients with interstitial cystitis (IC), an 
idiopathic disorder characterized by urinary frequency, urgency and pain, also manifest HPA 
dysregulation. Patients with IC display symptom exacerbation when exposed to stress. Specific data 
regarding the role of CRF directly on micturition are conflicting and incomplete. However, due to 
substantial cross-innervation of the colon and bladder, CRF, mediated through CRF-R1, would be 
expected to stimulate the bladder similar to its excitatory action on the colon6.  
 
The pelvic floor pathway 
We hypothise that pelvic floor dysfunction (PFD) is another link between sexual abuse history and 
OAB. The pelvic floor is known to be an integrated structure, influenced by psychological and 
physical causes. A higher prevalence of multiple pelvic floor complaints, like micturition, defecation 
and sexual pain, are seen in patients with sexual abuse history10. Davila et al reported significant 
more pelvic floor related urological complaints like dribbling, slow urinating stream and stress 
incontinence after SA11. The pelvic floor comprises several layers, including the pelvic diaphragm 
(levator ani and coccygeus muscles) and the urogenital diaphragm. Each diaphragm has its own 3D 
shape and position with regard to the internal pelvic organs. The urogenital diaphragm consists of a 
deep layer, the perineal membrane, and a superficial layer, consisting of the bulbospongiosus 
muscle and the ischiocavernosus muscle. The levator ani muscle is made up of the iliococcygeus, 
pubococcygeus, and puborectalis muscles. Together with the urethral and anal sphincters, these 
muscles play an important role in preventing complaints of micturition, defecation, sexual 
dysfunction, prolapse and/or pelvic floor pain. The development of one of these complaints is 
referred to as PFD12. It has been hypothesized that patients with PFD have voiding difficulties due to 
a higher tone at rest of the pelvic floor9;13,14. Many of them have episodes of obstructive urinating 
complaints. As in benign prostate hyperplasia, long-lasting bladder outlet obstruction (BOO) can 
lead to OAB symptoms15. Obstruction-induced changes in the bladder are of two basic types. First, 
the changes that lead to detrusor instability or decreased compliance are clinically associated with 
symptoms of frequency and urgency. Second, the changes associated with decreased detrusor 
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contractility are associated with further deterioration in the force of the urinary stream, hesitancy, 
intermittency, increased residual urine, and (in a minority of cases) detrusor failure16. Pelvic floor 
physiotherapy can be used to treat pelvic floor related BOO and thus relieving OAB symptoms17. 
Unfortunately randomised studies describing improvement of urological complaints in SA survivors 
treated with pelvic floor physiotherapy are not available. Still, we are convinced that SA can lead to 
PFD (e.g. pelvic floor overactivity) resulting in BOO, resulting in voiding symptoms and later on in 
torage symptoms (OAB). In women with interstitial cystitis/painful bladder syndrome (IC/PBS) two 
randomized clinical trials showed that myofascial physical therapy significantly improved patients 
bladder complaints compared to treatment with global therapeutic massage, indicating a role of the 
pelvic floor in bladder complaints18,19. We postulate an extra pathway to the existing Klausner-Steers 
model by adding the pelvic floor pathway. An overactive pelvic floor leads to BOO, which when long-
lasting leads to OAB, just as in OAB after BPH. The biological influence of stress and abuse on the 
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Figure 1: The Klausner-Steers model for emotional influence on the bladder 
 
Central stress response. In this model bladder inflammation sends nociceptive input to central nervous system via afferent 
nerves. Nociceptive stimuli are processed in amygdala which acts as relay station for processing emotional stress and visceral 
pain. Signals are relayed to hippocampus where memory processing occurs and can trigger peripheral stress response via HPA 
axis. Signals also project to prefrontal cortex for higher order processing and directly to Barrington's nucleus, projections are sent 
to locus ceruleus, which is rich norepinephrine (NE), and dorsal raphe nucleus, which is rich in serotonin (5-HT) and directly to 
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Conclusions and general discussion 
The primary aim of this study was to investigate the prevalence of sexual abuse in a urological 
outpatient clinic and to see if differences could have been made in urological populations, like a 
general urological clinic, a university urological clinic and a tertiary university pelvic floor clinic. 
Sexual abuse prevalence rates measured with female patients are respectively 13% in a general 
urological outpatient clinic (HagaZiekenhuis), 17% in an academic urological outpatient clinic 
(Leiden University Medical Center), 22% and 23% in a university outpatient pelvic floor center 
(University of Manitoba and LUMC)1-4. All prevalences are in the same range as the sexual abuse 
prevalence in general population. The conclusion is that patients with sexual abuse do not avoid the 
urologist, nor do they present themselves more often. There is a tendency that the more complex 
the urological pathology, the higher the prevalence of sexual abuse, which is climbing from 13% 
(normal urology clinic) to 17% (university urology clinic) to 22-23% (university pelvic floor center). 
The measured prevalence of male patients is 2%1. This is lower than the prevalence of 8%-10% 
mentioned in international literature, but comparable to the repeatedly measured Dutch prevalence 
of 4% in teenagers and adults5-8. The lower percentage of 2% can be explained by the research 
population in which age was higher than 60 on average and median. People under 60 are more 
willing to report a history of SA than people older than 609. The same significance was found in our 
study in which patients under 60 also reported sexual abuse more often1. Recall bias or 
embarrassment on this topic by an older generation can be an explanation for this low prevalence. 
Urologists are willing to ask their patients about sexual abuse history. Nearly 70% of Dutch 
urologists always ask their female patients about SA history. Those who doesn’t, do ask when a 
patient suffers from abdominal pain (78%) or urgency/frequency (62%)10. Although Dutch 
urologists frequently ask about sexual abuse, they underestimate the prevalence of sexual abuse. 
They estimate the prevalence to be 10% or less.  In contrast to sexual abuse, only 6% of the 
urologists ask all their female patients about female sexual dysfunctioning11. Most urologists ask 
about sexual dysfunction when a patient complains about lower abdominal pain (87%), incontinence 
(76%), urgency or frequency (71%), or urinary tract infections (66%). Urologists report a need for 
education and training about this topic. Most patients with sexual abuse history (72%) don’t mind if 
urologists ask about sexual abuse1. Although the study was not primarily designed to answer this 
question, urologists should not be afraid raising the topic of sexual abuse, because patients are not 
concerned by this inquiry. Although patients with sexual abuse don’t mind being asked about sexual 
abuse, half of them thought this information was not relevant for their urologist. Lack of knowledge 
of sexual abuse leading to urological complaints can be an explanation for this. Analysis of patient 
data of our academic pelvic floor population in Leiden showed that patients with sexual abuse had 
significantly more often complaints in more domains of the pelvic floor compared to pelvic floor 
patients without sexual abuse, suggesting that sexual abuse can lead to multiple pelvic floor related 
complaints2. In our Canadian pelvic floor study, we compared female patients with pelvic floor 
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complaints to patients without pelvic floor related complaints using the PeLFIs4. Looking more 
specified in the domains of the pelvic floor, it is shown that constipation, sexual dysfunction and 
urgency/frequency are all independently significant correlated with sexual abuse. Looking to 
urological complaints in an urological population, an association was found between a history of 
sexual abuse and urological complaints, namely a higher percentage of voiding complaints (63%), 
incontinence(61%) and urinary tract infections(53%) in the SA group, but the differences were not 
significant compared to patients without sexual abuse (voiding complaints 53%, incontinence 48% 
and urinary tract infections 44%)3. Remarkably patients with sexual abuse reported significant more 
urological complaints as reason for referral to the urologist.  A model was postulated to clarify the 
two main pathways in the mechanism of sexual abuse leading tot urological complaints12. The first 
pathway is the response of the pelvic floor pathway to stimuli, which leads to bladder outlet 
obstruction en over active bladder. The second pathway is the direct response to stimuli of the 
central nerve system on the bladder. More research is necessary to clarify the influences and the 
mechanisms responsible for the urological symptoms and its association with sexual abuse. More 
research is necessary to prove that urological complaints in relation to sexual abuse must be treated 
in a biological-psychological model with a combination of pelvic floor physiotherapy and 
psychological treatment. Randomised trials should be initiated to prove this. Urologist should not be 
afraid to inquire about sexual abuse because it’s relevant information for choosing the best 
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Chapter 1: Introduction. 
The primary aim of this study is to investigate the prevalence of sexual abuse in a urological 
outpatient clinic. Can differences been made in urological population, i.e. general urological clinic, a 
university urological clinic and a tertiary university pelvic floor clinic? Do urologists inquire about 
female sexual dysfunction and sexual abuse history? And if so, what percentage of the Dutch 
urologist does so? What do sexual abuse patients think about screening for sexual abuse history? 
Can we find predicting pelvic floor symptoms as a sign of sexual abuse history? And finally, do 
female urology patients with sexual abuse history more often present urological storage symptoms 
and/or pelvic floor complaints than patients without sexual abuse?  
 
Chapter 2: The place of female sexual dysfunction in the urological practice: results of a Dutch 
survey. 
Introduction: Female sexual dysfunction is a highly prevalent and often underestimated problem. 
There is a strong association between urological complaints and female sexual dysfunction. Aim: 
The purpose of this survey was to evaluate how Dutch urologists address female sexual dysfunction 
in their daily practice. Methods: We performed an anonymous survey study. A 17-item anonymous 
questionnaire was mailed to all 405 registered members of the Dutch Urology Association (urologists 
and residents in urology). Main Outcome Measures: The survey results. Results: One hundred 
eighty-six complete surveys of eligible respondents were returned (45.9% response rate). Ten 
respondents (5.5%) stated that they ask each female patient for sexual function; 87.1% stated that 
they ask for sexual function when a patient complains about lower abdominal pain (87.2%), 
incontinence (75.8%), urgency or frequency (70.5%), or urinary tract infections (65.8%). Many 
respondents (40.3%) do not think that female sexual dysfunction is meaningful in a urological 
practice. The majority of respondents (91%) underestimate the frequency of female sexual 
dysfunction in a urological clinic. Respondents who believe the frequency of female sexual 
dysfunction to be at least 30% tend to ask more often for sexual function than the rest of the group 
(p=0.08). Conclusions: Overall, many urologists do not consistently ask each female patient for 
sexual function and underestimate the prevalence of female sexual dysfunction. For the majority of 
the members of the Dutch Urological Association, female sexual dysfunction is not part of routine 
urological practice. There is, therefore, a need for better implementation of education and training 
at both undergraduate and postgraduate levels. 
 
Chapter 3: Female sexual abuse evaluation in the urological practice: results of a Dutch survey. 
Introduction: There is a strong association between urological complaints and a history of sexual 
abuse, especially in females. It is not known whether urologists integrate these facts in their daily 
practice. Aim: To evaluate whether Dutch urologists address the issues of sexual abuse in their 
female patients and to evaluate their perception of sexual abuse prevalence. Methods: A five-item 
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anonymous questionnaire was mailed to all 405 registered members of the Dutch Urology 
Association (urologists and residents). Main outcome measures: The results of the survey. 
Results: One hundred eighty-six surveys of eligible respondents were returned (45.9% response 
rate). A total of 68.8% stated that they always ask their female patients about sexual abuse before 
doing the physical examination. Overall, 79.3% said to do so when a patient has certain urological 
complaints: 77.6% in case of lower abdominal pain, 62.1% in urgency or frequency, 41.4% in 
incontinence, 29.3% in urinary tract infections, and 3.4% in haematuria. The majority of the 
respondents (74.3%) estimated the frequency of sexual abuse in their urological clinic to be equal 
or less than 10%. Conclusions: Nearly 70% of the responding Dutch urologists and residents ask 
their female patients about possible sexual abuse. They estimate the frequency of sexual abuse in 
their female patients to be equal or less than 10%. 
 
Chapter 4: Prevalence of sexual abuse among patients seeking general urological care.   
Introduction: Sexual abuse history can be found in the backgrounds of an important fraction of 
men (8-10%) and women (12-25%). Until now there are no data about this prevalence within a 
urological patient population. Aim: To establish the prevalence of sexual abuse among men and 
women visiting a urological outpatient clinic and to assess their opinion on screening for sexual 
abuse by urologists. Methods: A questionnaire to identify sexual abuse was translated into Dutch, 
English, and Turkish, and was adjusted for use in men. These questionnaires were anonymously 
distributed among 1,016 adult patients attending the urological outpatient clinic. Main outcome 
measure: The self-reported prevalence of sexual abuse. Secondary outcome measures were data 
about the assailant, victim's age at the time of the abuse, if the abuse was disclosed to the 
urologist, if the urologist had asked for sexual abuse and patient opinions on standard screening for 
sexual abuse in urological care. Results: A total of 878 questionnaires were returned, giving a total 
response rate of 86.4% (878/1,016). Thirty-three patients refused to participate. This resulted in 
845 filled-out questionnaires suited for analysis (845/1,016 = 83.2%). There were more male 
(75.7%) than female respondents (21.8%); 2.1% (13/624) and 13.0% (21/161) of the male and 
female respondents reported a history of sexual abuse, respectively. Almost 42% reported a 
stranger as assailant. In nearly 90%, the sexual abuse took place before adulthood: 56.2% in 
childhood and 31.2% in adolescence. Fifteen percent of the respondents with sexual abuse had it 
disclosed to their urologist. More than 70% of the abused respondents considered the idea to screen 
for sexual abuse in urological practice to be a good one. Conclusions: The prevalence of sexual 
abuse in patients seeking urological care in the Netherlands is 2.1% for men and 13.0% for women. 
 
Chapter 5: Multiple pelvic floor complaints are correlated with sexual abuse history. 
Introduction: The relationship between sexual abuse and urinary tract symptoms, sexual abuse 
and gastrointestinal symptoms, or sexual abuse and sexual dysfunction has been described before. 
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A correlation between all these symptoms and sexual abuse has not yet been reported. Aims: The 
first aim of this study was to document the prevalence rates of reported sexual abuse in a large 
sample of female patients with complaints of the pelvic floor. The second aim was to evaluate the 
frequency of complaints in the different domains of the pelvic floor, such as complaints of 
micturition, defecation, and sexual function, in female patients reporting sexual abuse, and 
comparing these data with female patients without a history of sexual abuse. Methods: Female 
patients with pelvic floor complaints were evaluated in a tertiary referral center. History taking was 
assessed by a pelvic-floor clinician. The number of domains with complaints of patients with a 
history of sexual abuse was compared with the number of domains with complaints of patients 
without sexual abuse. Main Outcome Measures: The number of patients who reported sexual 
abuse and the frequency of complaints in the different domains of the pelvic floor. The number of 
domains of patients with a history of sexual abuse was compared with patients without a history of 
sexual abuse. Results: Twenty-three percent (42/185) of the patients reported a history of sexual 
abuse. The female patients with a history of sexual abuse had  significantly more complaints in 
three domains of the pelvic floor (35/42) compared with the no abused (69/143) (83% vs. 48%, 
p<0.001). Conclusions: Twenty-three percent of the female patients in a pelvic floor center 
evaluated by a pelvic-floor clinician reported a history of sexual abuse. In our sample, the patients 
with multiple pelvic floor complaints (micturition, defecation, and sexual function) related to pelvic 
floor dysfunction were more likely to have a history of sexual abuse than the patients with isolated 
complaints.  
 
Chapter 6: Sexual abuse and pelvic floor complaints: a case-control study to identify which pelvic 
floor complaints are related to sexual abuse using the PeLFIs (a validated pelvic floor questionnaire). 
Introduction: Sexual abuse is present in about a quarter of female patients presenting with 
complaints of micturition, defecation and/or sexual function. The pelvic floor plays an important role 
in the aetiology of these complaints. Aim: To find out which complaints from the domains of the 
pelvic floor are correlated with sexual abuse. Methods: A case-control study in which an 
administered validated questionnaire the Pelvic floor Inventories (PeLFIs) was used to evaluate 55 
patients with pelvic floor dysfunction and 50 controls in a tertiary referral center in Canada. 
Complaints of the pelvic floor of patients with and without sexual abuse were compared. Main 
Outcome Measures: The survey results. Results: Patients with pelvic floor complaints showed a 
significantly higher percentage of sexual abuse (22%) compared to the control group (2.1%) 
(p=0.008). In the pelvic floor dysfunction group a history of SA correlated  significantly with 
complaints of constipation (p<0.01), sexual dysfunction (p<0.01) and urgency/frequency (p<0.01). 
Conclusion: In a pelvic floor population, constipation and/or sexual dysfunction and/or 




Chapter 7: Urological complaints and sexual abuse: a case control study identifying multiple 
urological complaints in relation to sexual abuse history. 
Introduction: The relationship between sexual abuse and urinary tract symptoms has been 
described for urgency, frequency and nocturia. Aims: To investigate if other urological 
complaints in females, like urinary tract infections, incontinence, voiding complaints and lower 
abdominal pain are also are correlated with a history of sexual abuse (SA) and to measure the 
prevalence of sexual abuse in our urological patient population, using a clinical case control 
study. Methods: 1383 female patients of 18-years or older visiting our outpatient urological 
university clinic were asked to fill out a questionnaire evaluating referral indications and 
urological complaints. The questionnaire consisted out of two parts. The fist was designed to 
collect data about demographic characteristics and medical history. The second part included 
referral indications, the urological complaints and a possible history of SA. The sample was 
divided into two groups: those with and those without a history of SA. The Outcome 
Measures: I. The comparison of the frequency of voiding complaints, urinary tract infections 
(UTI’s), lower abdominal pain, hematuria and incontinence in respondents with and without SA. 
II. The prevalence of SA in female patients presenting at our university urological outpatient 
clinic. III. The number of urological symptoms presented at the time of referral by respondents 
with a history of SA compared the non-abused. Results: 436/1383 (32%) patients were willing 
to participate. 304 (70%) questionnaires were properly filled in. The reported prevalence of 
sexual abuse was 17% (51/304). More than half of the females with a history SA presented with 
voiding complaints (32/51 p=0.18), incontinence (31/51 p=0.10) and urinary tract infections 
(27/51 p=0.22). However, comparing the data of respondents without SA we found no 
significant differences with regards specific complaints. Patients with SA report more symptoms 
than those without (Armitage’s trend test 0.14 (p=0.004) for 4 complaints or more). 
Conclusions: No significant correlation between SA and voiding complaints, incontinence nor 
lower abdominal pain was found. The prevalence rate of SA in female patients visiting our 
university urological outpatient clinic was 17%. These abused females mentioned more 
synchronous complaints as reason for referral at their first visit than the non-abused.   
 
Chapter 8: Sexual abuse and over active bladder: adding the pelvic floor pathway to the sexual 
abuse – over active bladder – model.  
Introduction: We review evidence linking pelvic floor dysfunction (PFD) to the current concept 
of sexual abuse (SA), overactive bladder (OAB) and corticotrophin releasing factor (CRF). 
Methods: We review the literature and add the pelvic floor pathway to the current Klausner-
Steers model for emotional influence on the bladder. Results: CRF is expressed in areas of the 
central nervous system that response to stress and is increased during anxiety and after SA. 
CRF is expressed in areas of the central nerve system that control voiding and response to 
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stress. Epidemiological and case control studies reveal an association between SA and PFD. PFD is 
related to long-lasting blad-der outlet obstruction (BOO), which can lead to OAB. Conclusions: PFD 
after SA is another link  between the relation of SA and OAB. Besides CRF and OAB as a therapeutic 
target, maybe pelvic floor physiotherapy can improve OAB after SA. We add the pelvic floor pathway  

























































































































































Hoofdstuk 1: Introductie. 
Het primaire doel van dit proefschrift is het bestuderen van de prevalentie van seksueel misbruik in 
een urologische populatie. Zijn er prevalentieverschillen tussen een polikliniek urologie van een 
algemeen ziekenhuis, een polikliniek urologie in een UMC en een academische bekken-
bodemcentrum? Vragen urologen hun patiënten naar seksueel misbruik in het verleden? Vragen 
urologen naar het seksueel functioneren van hun vrouwelijke patiënten? En als ze het doen, welk 
percentage van de urologen vraagt ernaar? Wat vinden patiënten met een verleden van seksueel 
misbruik ervan als de uroloog er naar vraagt? Zijn er bepaalde urologische of bekkenbodemklachten 
die vaker voorkomen bij slachtoffers van misbruik?  
 
Hoofdstuk 2: Het betrekken van vrouwelijke seksuele disfuncties in de urologische praktijk: 
resultaten van een Nederlandse enquête. 
Introductie: Vrouwelijk seksueel disfunctioneren is een vaak voorkomend en vaak onderschat 
probleem. Er is een sterke associatie tussen urologische klachten en vrouwelijk seksueel 
disfunctioneren. Doel: Het doel van deze enquête is het evalueren van het bespreekbaar maken 
van vrouwelijk seksueel disfunctioneren door urologen in hun dagelijkse werkzaamheden. 
Methode: Middels een anonieme enquête, waarbij een vragenlijst met 17 items naar alle 405 
geregistreerde leden van de Nederlandse Vereniging voor Urologie (urologen en artsen in opleiding 
tot specialist uroloog) is gestuurd. Belangrijkste uitkomstmaten: De resultaten van de enquête.  
Resultaten: 186 complete vragenlijsten van evenzoveel respondenten zijn  ontvangen (45.9% 
respons). Tien respondenten (5.5%) meldden dat ze alle vrouwen vragen naar het seksueel 
functioneren. De overigen vragen naar seksueel functioneren bij onderbuikspijnen (87.2%), 
incontinentie (75.8%), urgency of frequency (70.5%), of urineweginfecties (65.8%). Veel 
respondenten (40.3%) denken dat vrouwelijk seksueel disfunctioneren niet relevant is voor de 
urologische praktijkvoering. De overgrote meerderheid (91%) onderschat de prevalentie van 
vrouwelijk seksueel disfunctioneren in een urologische praktijk. Respondenten, die de prevalentie 
van vrouwelijk seksueel disfunctioneren schatten op minimaal 30%, vragen vaker naar vrouwelijk 
seksueel disfunctioneren dan de rest van de groep. (p=0.08). Conclusie: De meeste urologen 
vragen niet bij iedere patiënte naar vrouwelijk seksueel disfunctioneren en ze onderschatten de 
prevalentie ervan. Voor de meerderheid van de respondenten past vrouwelijk seksueel 
disfunctioneren niet in de algemene praktijkvoering. Er is behoefte aan beter onderwijs en training 
over dit onderwerp. 
 
Hoofdstuk 3: Vragen naar een verleden met seksueel misbruik bij vrouwelijke patiënten in de 
urologische praktijk: resultaten van een Nederlandse enquête. 
Introductie: Er is een verband tussen urologische klachten en een voorgeschiedenis met seksueel 
misbruik, vooral bij vrouwelijke patiënten. Het is niet bekend of urologen deze kennis integreren in 
118 
 
hun dagelijkse werkzaamheden, door ernaar te vragen. Doel: Evalueren of Nederlandse urologen 
seksueel misbruik ter sprake brengen en peilen wat de urologen schatten wat de prevalentie van 
seksueel misbruik zou zijn in hun urologische populatie. Methode: Een 5-item vragenlijst is 
verzonden naar alle 405 geregistreerde leden van de Nederlandse Vereniging voor Urologie 
(urologen en artsen in opleiding tot specialist uroloog). Belangrijkste uitkomstmaten: De 
resultaten van de enquête. Resultaten: 186  complete vragenlijsten van even zoveel respondenten 
zijn ontvangen (45.9% respons). Van de respondenten meldt 68.8% dat ze voor een lichamelijk 
onderzoek altijd vragen naar seksueel misbruik. Over het algemeen vraagt 79.3% er naar misbruik 
bij bepaalde klachten: 77.6% bij onderbuikspijn, 62.1% bij urgency of frequency, 41.4% bij 
incontinentie, 29.3% bij urineweginfecties en 3.4% bij hematurie. De meerderheid van de 
respondenten (74.3%) schat de prevalentie van seksueel misbruik bij hun patiënten op 10% of 
minder. Conclusie: Bijna 70% van de respondenten vraagt hun patiënten naar mogelijk seksueel 
misbruik. Zij schatten de prevalentie op 10% of minder.  
 
Hoofdstuk 4: Prevalentie van seksueel misbruik bij patiënten op een algemene polikliniek urologie.  
Introductie: De prevalentie van seksueel misbruik varieert van 8-10% bij mannen en 12-25% bij 
vrouwen. Tot nu toe zijn er geen gegevens over de prevalentie op een polikliniek urologie. Doel: 
Het meten van de prevalentie van een voorgeschiedenis met seksueel misbruik op een polikliniek 
urologie en het peilen van de mening van slachtoffers van seksueel misbruik naar het standaard 
screenen van de uroloog naar seksueel misbruik. Methode: Een vragenlijst over seksueel misbruik 
is vertaald naar het Nederlands, Engels en Turks. Tevens zijn de vragen aangepast aan mannelijke 
patiënten. Deze vragenlijst is uitgedeeld aan 1,016 volwassen poliklinische patiënten. Belang-
rijkste uitkomstmaten: De gerapporteerde prevalentie van seksueel misbruik. Secundaire 
uitkomstmaten zijn data over de dader van het misbruik, leeftijd waarop het misbruik plaatsvond, of 
de patiënt het misbruik had gemeld aan de uroloog, of de uroloog heeft gevraagd naar seksueel 
misbruik en wat de mening is van slachtoffers van seksueel misbruik naar de standaard vragen 
hiernaar. Resultaten: 878 ingevulde vragenlijsten kwamen retour, wat leidde tot een 
responspercentage van 86.4% (878/1,016). 31 patiënten weigerden deelname. Dit resulteerde in 
845 ingevulde vragenlijsten, die geschikt waren voor analyse (845/1,016 = 83.2%). Er waren meer 
mannelijke (75.7%) dan vrouwelijke respondenten (21.8%); 2.1% (13/624) van de mannen en 
13.0% (21/161) van de vrouwen melden een voorgeschiedenis met seksueel misbruik. Ruim 40% 
meldt een vreemde als dader. In bijna 90% vond het misbruik plaats voor volwassenheid: 56.2% 
tijdens de kinderjaren en 31.2% als adolescent. Meer dan 70% van de slachtoffers vindt het een 
goed idee als urologen standaard vragen naar seksueel misbruik. Conclusie: De prevalentie van 
seksueel misbruik op een algemene polikliniek urologie in Nederland is 2.1% voor mannen en 
13.0% voor vrouwen. Een ruime meerderheid van de slachtoffers vindt het een goed idee als de 
uroloog naar seksueel misbruik vraagt.  
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Hoofdstuk 5: Multipele klachten van de bekkenbodem zijn gecorreleerd met seksueel misbruik. 
Introductie: De relatie tussen seksueel misbruik en urologische klachten, seksueel misbruik en 
gastrointestinale klachten en seksueel misbruik en seksuele klachten zijn al eerder beschreven. 
Een correlatie tussen al deze klachten en seksueel misbruik is niet eerder beschreven. Doel: Het 
primaire doel van de studie is het meten van de prevalentie van seksueel misbruik in een grote 
groep patiënten met bekkenbodemproblematiek. Het tweede doel is het meten van de frequenties 
van de klachten in de diverse domeinen van de bekkenbodem in relatie tot seksueel misbruik en 
deze te vergelijken met patiënten met bekkenbodemproblematiek zonder seksueel misbruik in de 
voorgeschiedenis. Methode: Vrouwelijke patiënten met bekkenbodem-problematiek werden 
geanalyseerd op een academische bekkenbodem-polikliniek. Een bekkentherapeute nam de 
anamnese af. Het aantal domeinen met klachten bij patiënten met seksueel misbruik in het 
verleden, werd vergeleken met patiënten zonder seksueel misbruik.  
Belangrijkste uitkomstmaten: De prevalentie van seksueel misbruik. De frequentie van de 
domeinen van de bekkenbodem met klachten, vergeleken tussen patiënten met en zonder 
seksueel misbruik. Resultaten: 23% (42/185) van de patiënten meldt een verleden met seksueel 
misbruik. Patiënten met seksueel misbruik in het verleden meldden significant vaker klachten in 
drie domeinen van de bekkenbodem (35/42) vergeleken met patiënten zonder misbruik (69/143) 
(83% vs 48%,  p<0.001). Conclusie: 23% van de patiënten op een academische 
bekkenbodempolikliniek meldt een verleden met seksueel misbruik. Patiënten met multipele 
klachten van de bekkenbodem (mictieklachten, defecatieklachten en seksuele disfunctie) hadden 
vaker een verleden met seksueel misbruik dat patiënten met geïsoleerde klachten.  
 
Hoofdstuk 6: Seksueel misbruik en klachten van de bekkenbodem: een case-control studie die 
bestudeert welke klachten van de bekkenbodem zijn gerelateerd aan seksueel misbruik, 
gebruikmakend van de PeLFis (een gevalideerde bekkenbodem vragenlijst) . 
Introductie: Een voorgeschiedenis met seksueel misbruik is aanwezig bij ruim een kwart van de 
vrouwelijke patiënten met mictieklachten, defecatieklachten en/of seksuele disfunctie. De 
bekkenbodem speelt een belangrijke rol in de etiologie van deze klachten. Doel: Bestuderen 
welke klachten uit de domeinen van de bekkenbodem zijn gecorreleerd met seksueel misbruik. 
Methode: Een case-control studie waarbij een gevalideerde vragenlijst is gebruikt (PeLFis). 55 
patiënten met een bekkenbodem disfunctie zijn vergeleken met 50 controles. De studie vond  
plaats in een tertiair bekkenbodem centrum in Canada. Klachten van de bekkenbodem van 
patiënten met en zonder seksueel misbruik werden vergeleken. Belangrijkste uitkomstmaten: 
De resultaten van de enquête. Resultaten: In de groep patiënten met klachten van de 
bekkenbodem wordt vaker seksueel misbruik gerapporteerd (22%) dan in de controle groep (2%) 
(p=0.008). In de groep met patiënten met bekkenbodemklachten is seksueel misbruik significant 
gecorreleerd met constipatie (p<0.01), seksuele disfunctie (p<0.01) en urge / frequency  
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(p<0.01). Conclusie: In een populatie van patiënten met bekkenbodemklachten zijn constipatie 
en/of seksuele disfunctie en/of urge / frequency significant gecorreleerd met seksueel misbruik. 
 
Hoofdstuk 7: Urologische klachten en seksueel misbruik: een case-control studie om meerdere 
urologische klachten te bestuderen in relatie tot seksueel misbruik.  
Introductie: De relatie tussen seksueel misbruik en urinewegsymptomen is beschreven voor urge, 
frequency en nycturie. Doel: Bestuderen of andere urologische symptomen, zoals 
urineweginfecties, incontinentie, plasklachten en onderbuikspijn, gecorreleerd zijn met seksueel 
misbruik en het meten van de frequentie van seksueel misbruik op een poli urologie. Methode: 
1383 vrouwelijke patiënten van 18-jaar of ouder, die de polikliniek urologie bezochten van het 
LUMC, werden gevraagd een vragenlijst in te vullen over reden voor verwijzing en hun urologische 
klachten. De vragenlijst bestond uit twee delen. Het eerste deel verzamelde demografische 
gegevens en gegevens over de medische voorgeschiedenis. Het tweede gedeelte bevatte vragen 
over reden voor verwijzing, urologische klachten en de mogelijke aanwezigheid van seksueel 
misbruik. De groep werd verdeeld in patiënten met en zonder seksueel misbruik. Belangrijkste 
uitkomstmaten: I. Vergelijking van de frequentie van mictieklachten, urineweginfecties, 
onderbuikspijn, hematurie en incontinentie bij patiënten met en zonder seksueel misbruik. II. De 
prevalentie van seksueel misbruik bij vrouwelijke patiënten die onze polikliniek bezoeken. III. Het 
aantal synchrone urologische klachten als reden voor verwijzing, vergeleken bij patiënten met en 
zonder seksueel misbruik. Resultaten: 436/1383 (32%) patiënten waren bereid te participeren. 
304 (70%) vragenlijsten waren adequaat ingevuld. De gerapporteerde prevalentie van seksueel 
misbruik was 17% (51/304). Patiënten met seksueel misbruik in de voorgeschiedenis rapporteerden 
vaker mictieklachten (32/51 p=0.18), incontinentie (31/51 p=0.10) en urineweginfecties (27/51 
p=0.22). Echter zijn de verschillen niet significant vergeleken met patiënten zonder seksueel 
misbruik. Patiënten met seksueel misbruik melden meer synchrone urologische klachten als reden 
voor verwijzing dan patiënten zonder seksueel misbruik. (Armitage’s trend test 0.14 (p=0.004) bij 4 
klachten of meer). Conclusies: Er is geen significant verschil gevonden tussen patiënten met en 
zonder seksueel misbruik aangaande mictieklachten, incontinentie of onderbuikspijn. De prevalentie 
van seksueel misbruik in deze groep is 17%. Deze patiënten met seksueel misbruik melden 
significant meer synchrone urologische klachten als reden voor verwijzing.  
 
Hoofdstuk 8: Seksueel misbruik en overactieve blaas: toevoeging van de bekkenbodem aan het 
huidige seksueel misbruik – overactieve blaas- model.  
Introductie: We beoordelen de wetenschappelijke literatuur die een verband legt tussen 
bekkenbodemproblematiek en seksueel misbruik. Dit verband wordt geplaatst in het huidige model 
van seksueel misbruik – overactieve blaas en corticotrophin releasing factor (CRF). Methode: 
Bestuderen van de literatuur en toevoegen van de bekkenbodem route aan  het huidige Klausner-
121 
 
Steers model voor emotionele invloed op de blaas. Resultaten: CRF wordt gevonden in gebieden 
van het centrale zenuwstelsel die reageren op stress. CRF neemt toe bij angst en onder andere na 
seksueel misbruik. CRF wordt ook gevonden in gedeelten van het centrale zenuwstelsel die invloed 
hebben op de mictie. Epidemiologische en case-control studies leggen een relatie tussen seksueel 
misbruik en bekkenbodemklachten. Bekkenbodemklachten zijn een van de oorzaken van 
obstructieve mictie bij vrouwen. Langdurige obstructieve mictie leidt tot een overactieve blaas.  
Conclusies: Bekkenbodemklachten na seksueel misbruik zijn een andere link in de relatie tussen 
seksueel misbruik en overactieve blaas. Naast CRF en de overactieve blaas als aandachtspunt voor 
behandeling, kan bekkenbodem fysiotherapie worden overwogen als aandachtspunt voor 
behandeling. Wij voegen de bekkenbodem toe aan het huidige Klausner-Steers model voor de 
invloed van emoties op de blaas.  
 
Hoofdstuk 9: Conclusies en algemene discussie. 
Het primaire doel van deze studie was om de prevalentie van seksueel misbruik te onderzoeken in 
een urologische polikliniek en om te zien of verschillen kunnen zijn in urologische populaties, zoals 
een algemene urologische kliniek, een universiteitskliniek en een tertiaire universitaire 
bekkenbodemkliniek. De prevalentie is respectievelijk 13% in een algemene urologische polikliniek 
(HagaZiekenhuis), 17% in een academische urologische polikliniek (Leids Universitair Medisch 
Centrum), 22% en 23% in een universitaire poliklinische bekkenbodem centrum (Universiteit van 
Manitoba en LUMC). Alle prevalenties zijn in dezelfde orde van grootte als de prevalentie van 
seksueel misbruik in de algemene bevolking. De conclusie is dat patiënten met seksueel misbruik de 
uroloog niet mijden, noch presenteren zij zich vaker. Er is een tendens dat hoe complexer de  
urologische pathologie is, hoe hoger de prevalentie van seksueel misbruik. Van 13% (normale 
urologische kliniek) klimt de prevalentie naar 17% (universiteitskliniek) naar 22-23% (universitair 
bekkenbodem centrum). De gemeten prevalentie bij mannelijke patiënten is 2%. Dit is lager dan de 
prevalentie van 8%-10% vermeld in internationale literatuur, maar vergelijkbaar met de 
herhaaldelijk gemeten Nederlandse prevalentie van 4% in tieners en volwassenen. Het getal van 
2% kan worden verklaard door de onderzoekspopulatie, waarin de leeftijd hoger was dan 60. 
Mensen jonger dan 60 zijn eerder bereid om een geschiedenis van seksueel misbruik te rapporteren 
dan mensen die ouder zijn dan 60. Recall bias of verlegenheid over dit onderwerp door een oudere 
generatie kan een verklaring voor deze lage prevalentie zijn. Urologen zijn bereid om hun patiënten 
te vragen naar seksueel misbruik. Bijna 70% van de Nederlandse urologen vragen hun vrouwelijke 
patiënten altijd naar seksueel misbruik. Degenen die niet standaard vragen, doen het wel wanneer 
een patiënt lijdt aan buikpijn (78%) of aan urgency / frequency klachten (62%). Hoewel de 
Nederlandse urologen vaak vragen naar seksueel misbruik, onderschatten ze de prevalentie hiervan. 
Zij schatten de prevalentie op 10% of minder. In tegenstelling tot bij seksueel misbruik, vraagt 
slechts 6% van de urologen al hun vrouwelijke patiënten naar vrouwelijke seksueel disfunctioneren. 
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De meeste urologen vragen naar vrouwelijke seksueel disfunctioneren als een patiënt klaagt over 
pijn in de onderbuik (87%), incontinentie (76%), urgency/frequency (71%) of urineweginfecties 
(66%). Urologen rapporteren een behoefte aan onderwijs en opleiding over dit onderwerp. De 
meeste patiënten met seksueel misbruik in de voorgeschiedenis (72%) vinden het niet erg als 
urologen hier naar vragen. Hoewel patiënten met seksueel misbruik het niet erg vinden als er naar 
wordt gevraagd, geeft de helft van hen aan dat deze informatie niet relevant is voor hun uroloog. 
Gebrek aan kennis over de relatie tussen seksueel misbruik en urologische klachten kan  een 
verklaring hiervoor zijn. Analyse van patiëntengegevens van onze academische bekkenbodem 
populatie in Leiden toonde aan dat patiënten met seksueel misbruik significant vaker klachten 
hadden in meerdere domeinen van de bekkenbodem in vergelijking met patiënten zonder seksueel 
misbruik. Dit suggereert dat seksueel misbruik kan leiden tot meerdere aan de bekkenbodem 
gerelateerde klachten. In onze Canadese bekkenbodem studie hebben we vrouwelijke patiënten met 
bekkenbodem klachten vergeleken met patiënten zonder bekkenbodem klachten. In deze studie 
wordt aangetoond dat constipatie, seksuele disfunctie en urgency/frequency onafhankelijk van 
elkaar significant gecorreleerd zijn met seksueel misbruik. Zoekend naar urologische klachten in een 
urologische populatie werd een associatie gevonden tussen een geschiedenis van seksueel misbruik 
en urologische klachten, namelijk een hoger percentage plasklachten (63%), incontinentie (61%) en 
urineweginfecties (53%) in de seksueel misbruik groep, maar de verschillen waren niet significant in 
vergelijking met patiënten zonder seksueel misbruik (plasklachten 53%, incontinentie 48% en 
urineweginfecties 44%). Het is opmerkelijk dat patiënten met seksueel misbruik significant meer 
urologische klachten melden als reden voor verwijzing naar de uroloog. In een model wordt gesteld 
dat er twee belangrijkste wegen zijn die seksueel misbruik relateren aan urologische klachten. De 
eerste route verloopt via de bekkenbodem. De tweede route is de directe response van het centrale 
zenuwstelsel naar de blaas als reactie op stimuli. Meer onderzoek is nodig om de invloeden en de 
mechanismen te verklaren die verantwoordelijk zijn voor de relatie tussen een voorgeschiedenis met 
seksueel misbruik en urologische klachten. Aanvullend onderzoek is ook nodig om te bewijzen dat 
urologische klachten in relatie tot seksueel misbruik moet worden behandeld in een biologisch-
psychologisch model met een combinatie van bekkenbodem fysiotherapie en psychologische 
behandeling. Gerandomiseerde studies moeten opgezet worden om dit concept te bewijzen. 
Urologen moeten niet aarzelen om te informeren naar seksueel misbruik, want het is relevante 
informatie voor het kiezen van de beste behandeling opties voor de patiënt. Patiënten met seksueel 








































List of abbreviations 
 5-HT  5-hydroxytryptamine = serotonine 
ACTH  adrenocorticotropic hormone  
BOO  bladder outlet obstruction 
BPH  benign prostate hyperplasia 
CNS  central nervous system 
CRF  corticotrophin releasing factor 
FGID  functional gastro intestinal disorders 
FSD  female sexual dysfunction 
GI  gastrointestinal 
HPA  hypothalamic-pituitary-adrenal  
IC  interstitial cystitis 
IC/PBS  interstitial cystitis / painful bladder syndrom 
IPPC  incontinence and pelvic pain clinic 
NE  norepinephrine 
OAB  overactive bladder 
PeLFIs  pelvic floor inventories 
PFD  pelvic floor dysfunction 
PTSD  posttraumatic stress disorder  
PVN  paraventricular nucleus  
SA  sexual abuse 
SSRI’s  selective serotonine reuptake inhibitors 
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